Background  	Background  	 FW	B-NP
Plasminogen  	Plasminogen  	 FW	I-NP
activator  	activator  	 FW	I-NP
inhibitor-1  	inhibitor-1  	 FW	I-NP
( 	( 	 -LRB-	O
PAI-1 	PAI-1 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
serine  	serine  	 JJ	B-NP
proteinase  	proteinase  	 JJ	I-NP
inhibitor  	inhibitor  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
serpin  	serpin  	 JJ	O
superfamily  	superfamily  	 NNS	O
[  	[  	 -LRB-	O
1  	1  	 CD	O
2  	2  	 CD	O
3  	3  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
50  	50  	 CD	O
kDa  	kDa  	 JJ	B-NP
glycoprotein  	glycoprotein  	 NN	I-NP
is  	is  	 VBZ	O
apparently  	apparently  	 RB	O
the  	the  	 DT	O
most  	most  	 RBS	O
important  	important  	 JJ	O
physiological  	physiological  	 JJ	B-NP
inhibitor  	inhibitor  	 NN	I-NP
of  	of  	 IN	I-NP
tissue-type  	tissue-type  	 JJ	I-NP
plasminogen  	plasminogen  	 JJ	I-NP
activator  	activator  	 NNS	I-NP
( 	( 	 -LRB-	O
tPA 	tPA 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
of  	of  	 IN	O
urokinase  	urokinase  	 FW	B-NP
plasminogen  	plasminogen  	 FW	I-NP
activator  	activator  	 FW	I-NP
( 	( 	 -LRB-	O
uPA 	uPA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
[  	[  	 -LRB-	O
4  	4  	 LS	O
]  	]  	 -RRB-	O
It  	It  	 PRP	O
was  	was  	 VBD	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
play  	play  	 VB	O
a  	a  	 DT	O
crucial  	crucial  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
regulation  	regulation  	 NN	O
of  	of  	 IN	O
vascular  	vascular  	 JJ	B-NP
thrombosis 	thrombosis 	 NN	I-NP
,  	,  	 ,	O
tumor  	tumor  	 NN	B-NP
invasion 	invasion 	 NN	I-NP
,  	,  	 ,	O
neovascularization 	neovascularization 	 NN	B-NP
,  	,  	 ,	O
inflammation  	inflammation  	 NN	B-NP
and  	and  	 CC	O
wound  	wound  	 VBD	O
healing.  	healing.  	 CD	O
[  	[  	 -LRB-	O
5  	5  	 CD	O
6  	6  	 CD	O
]  	]  	 -RRB-	O
Increased  	Increased  	 VBN	O
plasma  	plasma  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
were  	were  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
correlated  	correlated  	 VBN	O
with  	with  	 IN	O
an  	an  	 DT	O
increased  	increased  	 JJ	O
risk  	risk  	 NN	O
for  	for  	 IN	O
cardiovascular  	cardiovascular  	 JJ	B-NP
diseases.  	diseases.  	 NNP	I-NP
[  	[  	 -LRB-	O
6  	6  	 CD	O
7  	7  	 CD	O
8  	8  	 CD	O
]  	]  	 -RRB-	O
The  	The  	 DT	O
essential  	essential  	 JJ	B-NP
function  	function  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 CD	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
fibrinolytic  	fibrinolytic  	 JJ	B-NP
system  	system  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
confirmed  	confirmed  	 VBN	O
by  	by  	 IN	O
studies  	studies  	 NNS	O
with  	with  	 IN	O
transgenic  	transgenic  	 CD	B-NP
animals.  	animals.  	 CD	I-NP
[  	[  	 -LRB-	O
7  	7  	 CD	O
9  	9  	 CD	O
]  	]  	 -RRB-	O
PAI-1  	PAI-1  	 CD	B-NP
shares  	shares  	 NNS	I-NP
a  	a  	 DT	O
35 	35 	 CD	O
%  	%  	 NN	O
homology  	homology  	 NN	B-NP
with  	with  	 IN	O
40  	40  	 CD	O
other  	other  	 JJ	O
serpins.  	serpins.  	 NNP	B-NP
[  	[  	 -LRB-	O
10  	10  	 CD	O
]  	]  	 -RRB-	O
The  	The  	 DT	O
X-ray  	X-ray  	 NN	B-NP
structure  	structure  	 NN	I-NP
of  	of  	 IN	O
active  	active  	 JJ	O
PAI-1  	PAI-1  	 NNP	B-NP
[  	[  	 -LRB-	O
11  	11  	 CD	O
12  	12  	 CD	O
]  	]  	 -RRB-	O
consists  	consists  	 VBZ	O
of  	of  	 IN	O
three  	three  	 CD	O
sheets  	sheets  	 NNS	O
( 	( 	 -LRB-	O
A-C 	A-C 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
nine  	nine  	 CD	O
helices  	helices  	 NNS	B-NP
( 	( 	 -LRB-	O
a-i 	a-i 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
a  	a  	 DT	O
reactive  	reactive  	 JJ	B-NP
center  	center  	 NN	I-NP
loop  	loop  	 NNS	I-NP
( 	( 	 -LRB-	O
RCL 	RCL 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
RCL  	RCL  	 NNP	B-NP
contains  	contains  	 VBZ	O
the  	the  	 DT	O
residues  	residues  	 JJ	O
Ser331  	Ser331  	 NN	B-NP
to  	to  	 TO	O
Arg356  	Arg356  	 CD	B-NP
( 	( 	 -LRB-	O
P16-P10 	P16-P10 	 NNP	B-NP
' 	' 	 POS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
within  	within  	 IN	O
it  	it  	 PRP	O
there  	there  	 EX	O
is  	is  	 VBZ	O
a  	a  	 DT	O
peptide  	peptide  	 JJ	B-NP
loop  	loop  	 NNS	I-NP
( 	( 	 -LRB-	O
Glu  	Glu  	 NNP	B-NP
351  	351  	 CD	O
to  	to  	 TO	O
Pro  	Pro  	 NNP	O
357 	357 	 CD	O
,  	,  	 ,	O
P5 	P5 	 NNP	B-NP
' 	' 	 POS	I-NP
-P11 	-P11 	 NNP	I-NP
' 	' 	 POS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
defined  	defined  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
hinge  	hinge  	 NNS	I-NP
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
It  	It  	 PRP	O
should  	should  	 MD	O
be  	be  	 VB	O
noted  	noted  	 VBN	O
that  	that  	 IN	O
the  	the  	 DT	O
placement  	placement  	 NN	O
and  	and  	 CC	O
conformation  	conformation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
RCL  	RCL  	 NNP	I-NP
in  	in  	 IN	O
active  	active  	 JJ	O
PAI-1  	PAI-1  	 NN	B-NP
is  	is  	 VBZ	O
quite  	quite  	 RB	O
different  	different  	 JJ	O
from  	from  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
latent  	latent  	 CD	O
PAI-1.  	PAI-1.  	 CD	B-NP
[  	[  	 -LRB-	O
13  	13  	 CD	O
]  	]  	 -RRB-	O
The  	The  	 DT	O
movement  	movement  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
hinge  	hinge  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
insertion  	insertion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
RCL  	RCL  	 NNP	B-NP
into  	into  	 IN	O
sheet  	sheet  	 NN	O
A  	A  	 NN	O
as  	as  	 IN	O
strand  	strand  	 CD	B-NP
4A  	4A  	 CD	I-NP
( 	( 	 -LRB-	O
s4A 	s4A 	 NNP	B-NP
)  	)  	 -RRB-	O
should  	should  	 MD	O
take  	take  	 VB	O
place  	place  	 NN	O
during  	during  	 IN	O
the  	the  	 DT	O
transition  	transition  	 NN	O
from  	from  	 IN	O
the  	the  	 DT	O
active  	active  	 JJ	O
into  	into  	 IN	O
the  	the  	 DT	O
latent  	latent  	 JJ	O
form  	form  	 NN	O
of  	of  	 IN	O
PAI-1 	PAI-1 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
catalytic  	catalytic  	 JJ	B-NP
center  	center  	 NN	I-NP
of  	of  	 IN	O
tPA  	tPA  	 JJ	O
interacts  	interacts  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
reactive  	reactive  	 JJ	B-NP
site  	site  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 CD	I-NP
with  	with  	 IN	O
concominant  	concominant  	 JJ	B-NP
formation  	formation  	 NN	I-NP
of  	of  	 IN	O
1 	1 	 CD	O
: 	: 	 :	O
1  	1  	 CD	O
molar 	molar 	 NN	B-NP
,  	,  	 ,	O
SDS-stable  	SDS-stable  	 JJ	B-NP
complex 	complex 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
P1  	P1  	 NNP	O
( 	( 	 -LRB-	O
Arg346 	Arg346 	 NNP	B-NP
)  	)  	 -RRB-	O
residue  	residue  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
RCL  	RCL  	 NNP	B-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
is  	is  	 VBZ	O
an  	an  	 DT	O
essential  	essential  	 JJ	B-NP
determinant  	determinant  	 NN	I-NP
for  	for  	 IN	O
its  	its  	 PRP$	O
target  	target  	 NN	B-NP
specificity  	specificity  	 NN	I-NP
and  	and  	 CC	O
inhibitory  	inhibitory  	 CD	B-NP
activity.  	activity.  	 CD	I-NP
[  	[  	 -LRB-	O
14  	14  	 CD	O
15  	15  	 CD	O
]  	]  	 -RRB-	O
Since  	Since  	 IN	O
many  	many  	 JJ	O
serpins  	serpins  	 NN	B-NP
with  	with  	 IN	O
identical  	identical  	 JJ	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
residue  	residue  	 NN	I-NP
at  	at  	 IN	O
P1  	P1  	 CD	B-NP
position  	position  	 NN	I-NP
display  	display  	 NN	I-NP
different  	different  	 JJ	O
specificities 	specificities 	 NN	O
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
unlikely  	unlikely  	 JJ	O
that  	that  	 IN	O
the  	the  	 DT	O
P1  	P1  	 JJ	B-NP
residue  	residue  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
sole  	sole  	 JJ	O
determinant  	determinant  	 NN	B-NP
for  	for  	 IN	I-NP
target  	target  	 NN	I-NP
protease  	protease  	 NN	I-NP
specificity 	specificity 	 NN	I-NP
,  	,  	 ,	O
other  	other  	 JJ	O
regions  	regions  	 NNS	O
of  	of  	 IN	O
PAI-1  	PAI-1  	 NNP	B-NP
may  	may  	 MD	O
also  	also  	 RB	O
affect  	affect  	 VB	O
its  	its  	 PRP$	O
specificity  	specificity  	 NN	O
toward  	toward  	 IN	O
target  	target  	 NN	B-NP
proteases 	proteases 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
variable  	variable  	 JJ	O
region  	region  	 NN	O
in  	in  	 IN	O
serine  	serine  	 JJ	B-NP
proteases  	proteases  	 JJ	I-NP
domain  	domain  	 NN	I-NP
determines  	determines  	 VBZ	O
their  	their  	 PRP$	O
specificity  	specificity  	 NN	O
for  	for  	 IN	O
PAI-1 	PAI-1 	 CD	B-NP
.  	.  	 .	O
Alignment  	Alignment  	 NNP	O
of  	of  	 IN	O
variable  	variable  	 JJ	O
region  	region  	 NN	O
1  	1  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
serine  	serine  	 JJ	B-NP
proteases  	proteases  	 NN	I-NP
shows  	shows  	 VBZ	O
a  	a  	 DT	O
remarkable  	remarkable  	 JJ	O
correlation  	correlation  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
composition  	composition  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
area  	area  	 NN	O
and  	and  	 CC	O
their  	their  	 PRP$	O
susceptibility  	susceptibility  	 NN	O
to  	to  	 TO	O
inhibition  	inhibition  	 VB	O
by  	by  	 IN	O
PAI-1  	PAI-1  	 NNP	B-NP
as  	as  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Table  	Table  	 NNP	O
2.  	2.  	 NNP	O
[  	[  	 -LRB-	O
16  	16  	 CD	O
]  	]  	 -RRB-	O
Both  	Both  	 DT	O
tPA  	tPA  	 JJ	O
and  	and  	 CC	O
uPA 	uPA 	 JJ	O
,  	,  	 ,	O
the  	the  	 DT	O
target  	target  	 NN	B-NP
proteases  	proteases  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1 	PAI-1 	 NNP	I-NP
,  	,  	 ,	O
contain  	contain  	 VBP	O
a  	a  	 DT	O
relatively  	relatively  	 RB	O
extensive  	extensive  	 JJ	B-NP
variable  	variable  	 JJ	I-NP
region  	region  	 NN	I-NP
1 	1 	 CD	O
,  	,  	 ,	O
consisting  	consisting  	 VBG	O
of  	of  	 IN	O
four  	four  	 CD	O
to  	to  	 TO	O
five  	five  	 CD	O
positively  	positively  	 RB	O
charged  	charged  	 VBN	O
amino  	amino  	 JJ	B-NP
acid  	acid  	 NN	I-NP
residues  	residues  	 NN	I-NP
present  	present  	 NN	O
at  	at  	 IN	O
identical  	identical  	 JJ	O
position 	position 	 NN	O
.  	.  	 .	O
Plasmin  	Plasmin  	 NNP	B-NP
and  	and  	 CC	O
thrombin  	thrombin  	 NN	B-NP
with  	with  	 IN	O
moderate  	moderate  	 JJ	O
reactivity  	reactivity  	 NN	B-NP
toward  	toward  	 IN	O
PAI-1  	PAI-1  	 NNP	B-NP
have  	have  	 VBP	O
relatively  	relatively  	 RB	O
short  	short  	 JJ	O
variable  	variable  	 JJ	O
regions  	regions  	 NNS	O
which  	which  	 WDT	O
contain  	contain  	 VBP	O
only  	only  	 RB	O
two  	two  	 CD	O
to  	to  	 TO	O
three  	three  	 CD	O
positively  	positively  	 RB	O
charged  	charged  	 VBN	O
residues 	residues 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
positively  	positively  	 RB	O
charged  	charged  	 VBN	O
amino  	amino  	 JJ	B-NP
acids  	acids  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
variable  	variable  	 JJ	O
region  	region  	 NN	O
of  	of  	 IN	O
tPA 	tPA 	 NNP	B-NP
,  	,  	 ,	O
uPA  	uPA  	 JJ	O
and  	and  	 CC	O
thrombin  	thrombin  	 NNS	B-NP
play  	play  	 VBP	O
dominant  	dominant  	 JJ	O
roles  	roles  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
PAI-1.  	PAI-1.  	 NNP	B-NP
[  	[  	 -LRB-	O
17  	17  	 CD	O
18  	18  	 CD	O
19  	19  	 CD	O
]  	]  	 -RRB-	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
Glu350  	Glu350  	 NNP	B-NP
( 	( 	 -LRB-	O
P4 	P4 	 NNP	O
' 	' 	 POS	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
PAI-1  	PAI-1  	 NNP	B-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
shown  	shown  	 VBN	O
to  	to  	 TO	O
mediate  	mediate  	 VB	O
the  	the  	 DT	O
interactions  	interactions  	 NN	B-NP
with  	with  	 IN	O
tPA.  	tPA.  	 NNP	B-NP
[  	[  	 -LRB-	O
18  	18  	 CD	O
]  	]  	 -RRB-	O
In  	In  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
By  	By  	 IN	O
producing  	producing  	 VBG	B-NP
wtPAI-1  	wtPAI-1  	 NNP	I-NP
and  	and  	 CC	O
several  	several  	 JJ	O
single  	single  	 JJ	O
site  	site  	 NN	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
hinge  	hinge  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 CD	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
baculovirus  	baculovirus  	 JJ	B-NP
expression  	expression  	 NN	I-NP
system 	system 	 NN	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
were  	were  	 VBD	O
able  	able  	 JJ	O
to  	to  	 TO	O
find  	find  	 VB	O
out  	out  	 RP	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
hinge  	hinge  	 NN	I-NP
in  	in  	 IN	O
conformational  	conformational  	 JJ	B-NP
transition  	transition  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
and  	and  	 CC	O
to  	to  	 TO	O
elucidate  	elucidate  	 VB	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
Glu351  	Glu351  	 CD	B-NP
in  	in  	 IN	O
PAI-1  	PAI-1  	 CD	B-NP
for  	for  	 IN	I-NP
serine  	serine  	 JJ	I-NP
protease  	protease  	 JJ	I-NP
specificities 	specificities 	 NN	I-NP
.  	.  	 .	O
Results  	Results  	 NNP	O
Characterization  	Characterization  	 NNP	B-NP
of  	of  	 IN	I-NP
wtPAI-1  	wtPAI-1  	 CD	I-NP
To  	To  	 TO	O
confirm  	confirm  	 VB	O
the  	the  	 DT	O
validity  	validity  	 NN	O
of  	of  	 IN	O
recombinant  	recombinant  	 JJ	B-NP
PAI-1  	PAI-1  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
model  	model  	 NN	O
to  	to  	 TO	O
study  	study  	 VB	O
the  	the  	 DT	O
native  	native  	 JJ	O
inhibitor  	inhibitor  	 JJ	B-NP
secreted  	secreted  	 NN	I-NP
from  	from  	 IN	O
human  	human  	 JJ	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
compared  	compared  	 VBD	O
the  	the  	 DT	O
recombinant  	recombinant  	 JJ	B-NP
PAI-1  	PAI-1  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
PAI-1  	PAI-1  	 CD	I-NP
first  	first  	 JJ	O
by  	by  	 IN	O
SDS-PAGE  	SDS-PAGE  	 JJ	B-NP
and  	and  	 CC	O
immunoblot  	immunoblot  	 NN	B-NP
with  	with  	 IN	O
anti-PAI-1  	anti-PAI-1  	 CD	B-NP
monoclonal  	monoclonal  	 CD	I-NP
antibodies 	antibodies 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
molecular  	molecular  	 JJ	B-NP
weight  	weight  	 NN	I-NP
of  	of  	 IN	I-NP
wtPAI-1  	wtPAI-1  	 NNP	I-NP
was  	was  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
lower  	lower  	 JJR	O
than  	than  	 IN	O
native  	native  	 JJ	O
PAI-1  	PAI-1  	 NNP	B-NP
( 	( 	 -LRB-	O
~50  	~50  	 NNP	O
kDa 	kDa 	 NNP	B-NP
,  	,  	 ,	O
Fig.  	Fig.  	 CD	O
1B 	1B 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
assumed  	assumed  	 VBD	O
that  	that  	 IN	O
this  	this  	 DT	O
is  	is  	 VBZ	O
due  	due  	 JJ	O
to  	to  	 TO	O
a  	a  	 DT	O
lower  	lower  	 JJR	O
( 	( 	 -LRB-	O
probably  	probably  	 RB	O
different 	different 	 JJ	O
)  	)  	 -RRB-	O
extent  	extent  	 NN	O
of  	of  	 IN	O
glycosylation  	glycosylation  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
baculovirus  	baculovirus  	 JJ	B-NP
expression  	expression  	 NN	I-NP
system 	system 	 NN	I-NP
.  	.  	 .	O
Indeed 	Indeed 	 RB	O
,  	,  	 ,	O
when  	when  	 WRB	O
both  	both  	 DT	O
proteins  	proteins  	 NNS	O
were  	were  	 VBD	O
deglycosylated  	deglycosylated  	 VBN	O
with  	with  	 IN	O
N-glycanase  	N-glycanase  	 JJ	B-NP
they  	they  	 PRP	O
were  	were  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
have  	have  	 VB	O
an  	an  	 DT	O
essentially  	essentially  	 RB	O
identical  	identical  	 JJ	O
M.W.  	M.W.  	 NNP	B-NP
( 	( 	 -LRB-	O
~48  	~48  	 NNP	O
kDa 	kDa 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
to  	to  	 TO	O
cross-react  	cross-react  	 JJ	O
immunochemically  	immunochemically  	 NNS	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
1B 	1B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
when  	when  	 WRB	O
this  	this  	 DT	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
was  	was  	 VBD	O
chromatographed  	chromatographed  	 VBN	O
on  	on  	 IN	O
heparin-Sepharose  	heparin-Sepharose  	 JJ	B-NP
it  	it  	 PRP	O
was  	was  	 VBD	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
>  	>  	 CD	O
98 	98 	 CD	O
%  	%  	 NN	O
pure  	pure  	 NN	O
by  	by  	 IN	O
silver  	silver  	 JJ	B-NP
staining  	staining  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
gel  	gel  	 NN	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
1Alane  	1Alane  	 CD	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Interestingly 	Interestingly 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
wtPAI  	wtPAI  	 NNP	I-NP
was  	was  	 VBD	O
63  	63  	 CD	O
±  	±  	 CD	O
15  	15  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
ug  	ug  	 VBD	I-NP
just  	just  	 RB	O
after  	after  	 IN	O
purification 	purification 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
to  	to  	 TO	O
84  	84  	 CD	O
±  	±  	 CD	O
21  	21  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
ug  	ug  	 NN	I-NP
after  	after  	 IN	O
denatured  	denatured  	 NN	O
by  	by  	 IN	O
6  	6  	 CD	O
M  	M  	 NNP	O
Gdn-HCl  	Gdn-HCl  	 NNP	B-NP
and  	and  	 CC	O
refolded  	refolded  	 NN	B-NP
in  	in  	 IN	O
50  	50  	 CD	O
mM  	mM  	 JJ	B-NP
sodium  	sodium  	 NN	I-NP
acetate  	acetate  	 NNS	I-NP
( 	( 	 -LRB-	O
pH  	pH  	 NNP	B-NP
5.6 	5.6 	 CD	O
)  	)  	 -RRB-	O
at  	at  	 IN	O
4°C 	4°C 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
contrast 	contrast 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
activity  	activity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
PAI-1  	PAI-1  	 NN	I-NP
was  	was  	 VBD	O
only  	only  	 RB	O
5  	5  	 CD	O
±  	±  	 CD	O
3  	3  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
ug  	ug  	 NN	I-NP
before  	before  	 IN	O
activation 	activation 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
was  	was  	 VBD	O
only  	only  	 RB	O
increased  	increased  	 VBN	O
to  	to  	 TO	O
45  	45  	 CD	O
±  	±  	 CD	O
16  	16  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
μg  	μg  	 NN	I-NP
after  	after  	 IN	O
denaturing  	denaturing  	 NN	B-NP
and  	and  	 CC	O
refolding 	refolding 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
high  	high  	 JJ	O
specific  	specific  	 JJ	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
wt-PAI-1  	wt-PAI-1  	 NNP	I-NP
could  	could  	 MD	O
be  	be  	 VB	O
due  	due  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
fact  	fact  	 NN	O
that  	that  	 IN	O
it  	it  	 PRP	O
was  	was  	 VBD	O
secreted  	secreted  	 VBN	O
from  	from  	 IN	O
insect  	insect  	 CD	B-NP
High-5  	High-5  	 CD	I-NP
cells  	cells  	 NNS	I-NP
cultured  	cultured  	 VBN	O
at  	at  	 IN	O
27°C 	27°C 	 NNP	O
,  	,  	 ,	O
while  	while  	 IN	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
preparation  	preparation  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
was  	was  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
the  	the  	 DT	O
medium  	medium  	 NN	O
of  	of  	 IN	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
cultured  	cultured  	 VBN	O
at  	at  	 IN	O
37°C  	37°C  	 NNP	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Exposure  	Exposure  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
higher  	higher  	 JJR	O
temperature  	temperature  	 NN	O
could  	could  	 MD	O
accelerate  	accelerate  	 VB	O
the  	the  	 DT	O
conversion  	conversion  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
inhibitor  	inhibitor  	 NN	O
into  	into  	 IN	O
its  	its  	 PRP$	O
latent  	latent  	 JJ	O
form 	form 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
functional  	functional  	 JJ	B-NP
stability  	stability  	 NN	I-NP
of  	of  	 IN	I-NP
wtPAI-1  	wtPAI-1  	 NNP	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
PAI-1  	PAI-1  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
or  	or  	 CC	O
in  	in  	 IN	O
presence  	presence  	 NN	O
of  	of  	 IN	O
vitronectin  	vitronectin  	 NNS	B-NP
are  	are  	 VBP	O
illustrated  	illustrated  	 VBN	O
in  	in  	 IN	O
Figure  	Figure  	 NNP	O
1C.  	1C.  	 NNP	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
lost  	lost  	 VBD	O
its  	its  	 PRP$	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
pace  	pace  	 NN	O
as  	as  	 IN	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
PAI-1 	PAI-1 	 NN	I-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
that  	that  	 IN	O
its  	its  	 PRP$	O
functional  	functional  	 JJ	B-NP
half  	half  	 NN	I-NP
life  	life  	 NN	I-NP
as  	as  	 IN	O
an  	an  	 DT	O
inhibitor  	inhibitor  	 NN	O
and  	and  	 CC	O
its  	its  	 PRP$	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
be  	be  	 VB	O
stabilized  	stabilized  	 VBN	O
by  	by  	 IN	O
vitronectin  	vitronectin  	 NNS	B-NP
are  	are  	 VBP	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
those  	those  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
PAI-1 	PAI-1 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
second-order  	second-order  	 JJ	B-NP
rate  	rate  	 NN	I-NP
constants  	constants  	 NNS	I-NP
( 	( 	 -LRB-	O
in  	in  	 IN	O
M  	M  	 NNP	O
-1s  	-1s  	 NNP	O
-1units 	-1units 	 NNP	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
PAI-1  	PAI-1  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
wtPAI-1  	wtPAI-1  	 NN	B-NP
towards  	towards  	 IN	O
t-PA  	t-PA  	 NNP	B-NP
were  	were  	 VBD	O
1.4  	1.4  	 CD	O
±  	±  	 CD	O
0.5  	0.5  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
7and  	7and  	 CD	O
1.7  	1.7  	 CD	O
±  	±  	 CD	O
0.6  	0.6  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
7 	7 	 CD	O
,  	,  	 ,	O
and  	and  	 CC	O
towards  	towards  	 IN	O
uPA  	uPA  	 NNP	B-NP
were  	were  	 VBD	O
4.1  	4.1  	 CD	O
±  	±  	 CD	O
1.4  	1.4  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
7and  	7and  	 CD	O
4.4  	4.4  	 CD	O
±  	±  	 CD	O
1.6  	1.6  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
7 	7 	 CD	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
show  	show  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
could  	could  	 MD	O
inhibit  	inhibit  	 VB	O
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA  	uPA  	 JJ	O
at  	at  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
rate  	rate  	 NN	O
as  	as  	 IN	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
PAI-1 	PAI-1 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
known  	known  	 VBN	O
that  	that  	 IN	O
PAI-1  	PAI-1  	 CD	B-NP
inhibits  	inhibits  	 NNS	O
either  	either  	 CC	O
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA  	uPA  	 JJ	O
by  	by  	 IN	O
forming  	forming  	 VBG	O
a  	a  	 DT	O
1 	1 	 CD	O
: 	: 	 :	O
1  	1  	 CD	O
SDS  	SDS  	 JJ	B-NP
stable  	stable  	 JJ	I-NP
complex  	complex  	 NN	I-NP
[  	[  	 -LRB-	O
4  	4  	 LS	O
]  	]  	 -RRB-	O
,  	,  	 ,	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
indeed  	indeed  	 RB	O
could  	could  	 MD	O
form  	form  	 VB	O
SDS  	SDS  	 JJ	B-NP
stable  	stable  	 JJ	I-NP
complex  	complex  	 NN	I-NP
with  	with  	 IN	O
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA  	uPA  	 NNP	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
3A 	3A 	 NNP	O
)  	)  	 -RRB-	O
just  	just  	 RB	O
as  	as  	 IN	O
fibrosarcoma  	fibrosarcoma  	 CD	B-NP
PAI-1 	PAI-1 	 CD	I-NP
.  	.  	 .	O
Single  	Single  	 JJ	B-NP
site  	site  	 NN	I-NP
mutations  	mutations  	 NNS	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
distal  	distal  	 JJ	B-NP
hinge  	hinge  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 CD	I-NP
Since  	Since  	 IN	O
a  	a  	 DT	O
proline  	proline  	 NN	B-NP
occurs  	occurs  	 VBZ	O
not  	not  	 RB	O
only  	only  	 RB	O
in  	in  	 IN	O
position  	position  	 NN	O
357  	357  	 CD	O
of  	of  	 IN	O
PAI-1 	PAI-1 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
also  	also  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
corresponding  	corresponding  	 JJ	O
position  	position  	 NN	O
of  	of  	 IN	O
several  	several  	 JJ	O
other  	other  	 JJ	O
serpins  	serpins  	 NNS	B-NP
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
)  	)  	 -RRB-	O
we  	we  	 PRP	O
attempted  	attempted  	 VBD	O
to  	to  	 TO	O
find  	find  	 VB	O
out  	out  	 RP	O
how  	how  	 WRB	O
does  	does  	 VBZ	O
a  	a  	 DT	O
mutation  	mutation  	 NN	O
of  	of  	 IN	O
P357  	P357  	 RB	O
affect  	affect  	 VB	O
the  	the  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1 	PAI-1 	 CD	I-NP
.  	.  	 .	O
Mutant  	Mutant  	 NNP	B-NP
of  	of  	 IN	O
Pro357Gly  	Pro357Gly  	 NNP	O
blocked  	blocked  	 VBD	O
the  	the  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
2A 	2A 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Similarly 	Similarly 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
mutation  	mutation  	 NN	O
into  	into  	 IN	O
proline  	proline  	 NN	B-NP
of  	of  	 IN	O
either  	either  	 DT	O
Asp355  	Asp355  	 NNP	B-NP
or  	or  	 CC	O
Arg356  	Arg356  	 NNP	B-NP
also  	also  	 RB	O
inactivated  	inactivated  	 VB	O
the  	the  	 DT	O
inhibitor 	inhibitor 	 NN	O
.  	.  	 .	O
It  	It  	 PRP	O
should  	should  	 MD	O
be  	be  	 VB	O
noted  	noted  	 VBN	O
that  	that  	 IN	O
all  	all  	 PDT	O
these  	these  	 DT	O
mutants  	mutants  	 NN	B-NP
could  	could  	 MD	O
be  	be  	 VB	O
activated  	activated  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
similar  	similar  	 JJ	O
extent  	extent  	 NN	O
by  	by  	 IN	O
6  	6  	 CD	O
M  	M  	 NNP	O
Gnd-HCl  	Gnd-HCl  	 NNP	B-NP
( 	( 	 -LRB-	O
~20 	~20 	 NNP	O
%  	%  	 NN	O
inhibitory  	inhibitory  	 NN	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
wtPAI-1 	wtPAI-1 	 NNP	I-NP
,  	,  	 ,	O
activated  	activated  	 VBN	O
under  	under  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
conditions 	conditions 	 NNS	O
) 	) 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
site  	site  	 NN	O
mutation  	mutation  	 NN	O
at  	at  	 IN	O
either  	either  	 DT	O
one  	one  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
positions  	positions  	 NNS	O
355 	355 	 CD	O
,  	,  	 ,	O
356  	356  	 CD	O
or  	or  	 CC	O
357  	357  	 CD	O
significantly  	significantly  	 RB	O
inactivates  	inactivates  	 JJ	O
PAI-1 	PAI-1 	 NN	B-NP
.  	.  	 .	O
To  	To  	 TO	O
elucidate  	elucidate  	 VB	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
through  	through  	 IN	O
which  	which  	 WDT	O
such  	such  	 JJ	O
mutations  	mutations  	 NNS	O
affect  	affect  	 VBP	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
PAI-1 	PAI-1 	 NNP	B-NP
,  	,  	 ,	O
we  	we  	 PRP	O
determined  	determined  	 VBD	O
their  	their  	 PRP$	O
effect  	effect  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
stability  	stability  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
and  	and  	 CC	O
on  	on  	 IN	O
its  	its  	 PRP$	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
form  	form  	 VB	O
an  	an  	 DT	O
SDS  	SDS  	 NNP	B-NP
stable  	stable  	 JJ	O
complex  	complex  	 NN	O
with  	with  	 IN	O
either  	either  	 DT	O
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA 	uPA 	 JJ	O
.  	.  	 .	O
As  	As  	 RB	O
seen  	seen  	 VBN	O
in  	in  	 IN	O
Fig.  	Fig.  	 CD	O
2B 	2B 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
rate  	rate  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
spontaneous  	spontaneous  	 JJ	B-NP
inactivation  	inactivation  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
inhibitor  	inhibitor  	 NN	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
increased  	increased  	 VBN	O
upon  	upon  	 IN	O
mutation 	mutation 	 NN	O
:  	:  	 :	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
half  	half  	 NN	I-NP
life  	life  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
mutants  	mutants  	 JJ	O
Asp355Pro 	Asp355Pro 	 NN	O
,  	,  	 ,	O
Arg356Pro  	Arg356Pro  	 NNP	O
and  	and  	 CC	O
Pro357Gly  	Pro357Gly  	 NNP	O
was  	was  	 VBD	O
23.8  	23.8  	 CD	O
±  	±  	 CD	O
4.5  	4.5  	 CD	O
min 	min 	 NN	B-NP
,  	,  	 ,	O
26.2  	26.2  	 CD	O
±  	±  	 CD	O
3.7  	3.7  	 CD	O
min  	min  	 NNS	B-NP
and  	and  	 CC	O
24.7  	24.7  	 CD	O
±  	±  	 CD	O
4.8  	4.8  	 CD	O
min 	min 	 NN	B-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
,  	,  	 ,	O
while  	while  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
was  	was  	 VBD	O
89.8  	89.8  	 CD	O
±  	±  	 CD	O
8.7  	8.7  	 CD	O
min 	min 	 NNS	B-NP
.  	.  	 .	O
Interestingly 	Interestingly 	 RB	O
,  	,  	 ,	O
there  	there  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
between  	between  	 IN	O
the  	the  	 DT	O
mutants  	mutants  	 JJ	B-NP
tested  	tested  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
wtPAI-1  	wtPAI-1  	 NN	B-NP
in  	in  	 IN	O
their  	their  	 PRP$	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
inactivate  	inactivate  	 VB	O
either  	either  	 DT	O
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA  	uPA  	 NNP	B-NP
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
3 	3 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
They  	They  	 PRP	O
could  	could  	 MD	O
also  	also  	 RB	O
form  	form  	 VB	O
SDS-stable  	SDS-stable  	 JJ	B-NP
complexes  	complexes  	 NNS	I-NP
with  	with  	 IN	O
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA  	uPA  	 JJ	O
just  	just  	 RB	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
3A 	3A 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
An  	An  	 DT	O
interesting  	interesting  	 JJ	O
structural  	structural  	 JJ	B-NP
similarity  	similarity  	 NN	I-NP
among  	among  	 IN	O
several  	several  	 JJ	O
serpins  	serpins  	 NN	B-NP
is  	is  	 VBZ	O
known  	known  	 VBN	O
to  	to  	 TO	O
occur  	occur  	 VB	O
at  	at  	 IN	O
the  	the  	 DT	O
position  	position  	 NN	B-NP
corresponding  	corresponding  	 NN	I-NP
to  	to  	 TO	O
355  	355  	 CD	O
in  	in  	 IN	O
PAI-1 	PAI-1 	 CD	B-NP
.  	.  	 .	O
While  	While  	 IN	O
in  	in  	 IN	O
PAI-1  	PAI-1  	 CD	B-NP
this  	this  	 DT	O
position  	position  	 NN	O
accommodates  	accommodates  	 VBD	O
a  	a  	 DT	O
negatively  	negatively  	 RB	O
charged  	charged  	 VBN	O
aspartic  	aspartic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
residue 	residue 	 NN	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
other  	other  	 JJ	O
serpins  	serpins  	 NN	B-NP
it  	it  	 PRP	O
sometimes  	sometimes  	 RB	O
accommodates  	accommodates  	 VB	O
its  	its  	 PRP$	O
non  	non  	 FW	B-NP
charged  	charged  	 FW	I-NP
analog  	analog  	 FW	I-NP
asparagine  	asparagine  	 FW	I-NP
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Asp355His 	Asp355His 	 NNP	O
,  	,  	 ,	O
Asp355Lys 	Asp355Lys 	 NNP	O
,  	,  	 ,	O
Asp355Glu 	Asp355Glu 	 NNP	O
,  	,  	 ,	O
Asp355Gln  	Asp355Gln  	 NNP	O
and  	and  	 CC	O
Asp355Asn  	Asp355Asn  	 NNP	O
were  	were  	 VBD	O
prepared  	prepared  	 VBN	O
and  	and  	 CC	O
used  	used  	 VBN	O
to  	to  	 TO	O
show  	show  	 VB	O
that  	that  	 IN	O
the  	the  	 DT	O
negatively  	negatively  	 RB	O
charged  	charged  	 VBN	O
aspartic  	aspartic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
in  	in  	 IN	O
PAI-1  	PAI-1  	 NNP	B-NP
is  	is  	 VBZ	O
essential  	essential  	 JJ	O
( 	( 	 -LRB-	O
though  	though  	 RB	O
not  	not  	 RB	O
sufficient 	sufficient 	 JJ	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
its  	its  	 PRP$	O
inhibitory  	inhibitory  	 JJ	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
Asp355  	Asp355  	 CD	B-NP
by  	by  	 IN	O
asparagine  	asparagine  	 NNS	B-NP
( 	( 	 -LRB-	O
the  	the  	 DT	O
non  	non  	 NN	B-NP
charged  	charged  	 VBD	O
analog  	analog  	 VBN	O
of  	of  	 IN	O
aspartic  	aspartic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
by  	by  	 IN	O
histidine  	histidine  	 NN	B-NP
or  	or  	 CC	O
lysine  	lysine  	 NNS	B-NP
( 	( 	 -LRB-	O
that  	that  	 WDT	O
have  	have  	 VBP	O
a  	a  	 DT	O
positively  	positively  	 RB	O
charged  	charged  	 VBN	B-NP
side  	side  	 NN	I-NP
chain 	chain 	 NN	I-NP
)  	)  	 -RRB-	O
or  	or  	 CC	O
by  	by  	 IN	O
alanine  	alanine  	 NNS	B-NP
( 	( 	 -LRB-	O
neutral 	neutral 	 LS	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
inactivated  	inactivated  	 CD	B-NP
PAI-1 	PAI-1 	 CD	I-NP
.  	.  	 .	O
Replacement  	Replacement  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
aspartic  	aspartic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
residue  	residue  	 VBZ	I-NP
even  	even  	 RB	O
by  	by  	 IN	O
the  	the  	 DT	O
negatively  	negatively  	 RB	O
charged  	charged  	 VBN	O
glutamic  	glutamic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
( 	( 	 -LRB-	O
a  	a  	 DT	O
very  	very  	 RB	O
close  	close  	 VB	O
analog  	analog  	 VBN	O
of  	of  	 IN	O
aspartic  	aspartic  	 JJ	B-NP
acid 	acid 	 NN	I-NP
)  	)  	 -RRB-	O
did  	did  	 VBD	O
not  	not  	 RB	O
significantly  	significantly  	 RB	O
suffice  	suffice  	 VB	O
to  	to  	 TO	O
restore  	restore  	 VB	O
a  	a  	 DT	O
full  	full  	 JJ	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
3B 	3B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
After  	After  	 IN	O
activation  	activation  	 NN	B-NP
with  	with  	 IN	O
6  	6  	 CD	O
M  	M  	 NNP	O
Gnd-HCl 	Gnd-HCl 	 NNP	B-NP
,  	,  	 ,	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
six  	six  	 CD	O
mutants  	mutants  	 NNS	B-NP
exhibited  	exhibited  	 VBP	O
a  	a  	 DT	O
relatively  	relatively  	 RB	O
high  	high  	 JJ	O
inhibitory  	inhibitory  	 JJ	B-NP
activity 	activity 	 NN	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
their  	their  	 PRP$	O
specific  	specific  	 JJ	O
activities  	activities  	 NNS	O
were  	were  	 VBD	O
still  	still  	 RB	O
much  	much  	 RB	O
lower  	lower  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
3B 	3B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Among  	Among  	 IN	O
them 	them 	 PRP	O
,  	,  	 ,	O
Asp355Lys  	Asp355Lys  	 NNP	O
( 	( 	 -LRB-	O
5.1  	5.1  	 CD	O
±  	±  	 CD	O
4.1  	4.1  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 CD	I-NP
ug 	ug 	 CD	I-NP
)  	)  	 -RRB-	O
had  	had  	 VBD	O
the  	the  	 DT	O
lowest  	lowest  	 JJS	O
specific  	specific  	 JJ	O
activity 	activity 	 NN	O
,  	,  	 ,	O
while  	while  	 IN	O
the  	the  	 DT	O
Asp355Asn  	Asp355Asn  	 NNP	O
( 	( 	 -LRB-	O
20  	20  	 CD	O
±  	±  	 CD	O
4.2  	4.2  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 CD	I-NP
μg 	μg 	 CD	I-NP
)  	)  	 -RRB-	O
had  	had  	 VBD	O
the  	the  	 DT	O
highest  	highest  	 JJS	O
specific  	specific  	 JJ	O
activity  	activity  	 NN	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
3B 	3B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Although  	Although  	 IN	O
they  	they  	 PRP	O
had  	had  	 VBD	O
lower  	lower  	 RBR	O
specific  	specific  	 JJ	O
activities 	activities 	 NNS	O
,  	,  	 ,	O
all  	all  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
mutants  	mutants  	 NN	B-NP
mentioned  	mentioned  	 VBD	O
above  	above  	 RB	O
could  	could  	 MD	O
still  	still  	 RB	O
form  	form  	 VB	O
SDS-stable  	SDS-stable  	 JJ	B-NP
complexes  	complexes  	 NNS	I-NP
with  	with  	 IN	O
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA  	uPA  	 JJ	O
just  	just  	 RB	O
as  	as  	 IN	O
the  	the  	 DT	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
( 	( 	 -LRB-	O
data  	data  	 NNS	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Two  	Two  	 CD	O
additional  	additional  	 JJ	O
mutations 	mutations 	 NNS	O
,  	,  	 ,	O
Arg356Ala  	Arg356Ala  	 NNP	O
and  	and  	 CC	O
Arg356Glu 	Arg356Glu 	 NNP	O
,  	,  	 ,	O
were  	were  	 VBD	O
prepared  	prepared  	 VBN	O
to  	to  	 TO	O
further  	further  	 VB	O
elucidate  	elucidate  	 VBN	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
Arg356 	Arg356 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
specific  	specific  	 JJ	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	O
Arg356Ala  	Arg356Ala  	 NNP	O
was  	was  	 VBD	O
7.2  	7.2  	 CD	O
±  	±  	 CD	O
2.5  	2.5  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
μg 	μg 	 NN	I-NP
,  	,  	 ,	O
while  	while  	 IN	O
Arg356Glu  	Arg356Glu  	 CD	O
exhibited  	exhibited  	 NNS	O
essentially  	essentially  	 RB	O
no  	no  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
specific  	specific  	 JJ	O
activity  	activity  	 NN	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
to  	to  	 TO	O
35.4  	35.4  	 CD	O
±  	±  	 CD	O
8.7  	8.7  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
ug  	ug  	 NN	I-NP
for  	for  	 IN	O
Arg356Ala  	Arg356Ala  	 NNP	O
and  	and  	 CC	O
6.4  	6.4  	 CD	O
±  	±  	 CD	O
2.3  	2.3  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
μg  	μg  	 NN	I-NP
for  	for  	 IN	O
Arg356Glu  	Arg356Glu  	 CD	O
after  	after  	 IN	O
denature  	denature  	 NN	B-NP
and  	and  	 CC	O
refolding 	refolding 	 NN	B-NP
.  	.  	 .	O
Just  	Just  	 RB	O
like  	like  	 IN	O
ARG356Pro 	ARG356Pro 	 NNP	O
,  	,  	 ,	O
Arg356Ala  	Arg356Ala  	 NNP	O
and  	and  	 CC	O
Arg356Glu  	Arg356Glu  	 NNP	O
were  	were  	 VBD	O
much  	much  	 RB	O
more  	more  	 JJR	O
labile  	labile  	 NN	B-NP
than  	than  	 IN	O
wtPAI-1 	wtPAI-1 	 CD	B-NP
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
role  	role  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Asp355-Pro357  	Asp355-Pro357  	 JJ	B-NP
segment  	segment  	 NN	I-NP
is  	is  	 VBZ	O
to  	to  	 TO	O
stabilize  	stabilize  	 VB	O
the  	the  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
conformation  	conformation  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1 	PAI-1 	 CD	I-NP
.  	.  	 .	O
Specific  	Specific  	 JJ	O
activity 	activity 	 NN	O
,  	,  	 ,	O
functional  	functional  	 JJ	B-NP
stability  	stability  	 NN	I-NP
and  	and  	 CC	O
complex  	complex  	 JJ	O
formation  	formation  	 NN	O
of  	of  	 IN	O
Glu351Ala  	Glu351Ala  	 NNP	O
and  	and  	 CC	O
Glu351Arg  	Glu351Arg  	 CD	O
The  	The  	 DT	O
specific  	specific  	 JJ	O
inhibitory  	inhibitory  	 JJ	B-NP
activities  	activities  	 NNS	I-NP
of  	of  	 IN	I-NP
wtPAI-1 	wtPAI-1 	 NNP	I-NP
,  	,  	 ,	O
Glu351Ala  	Glu351Ala  	 NNP	O
and  	and  	 CC	O
Glu351Arg  	Glu351Arg  	 NNP	O
were  	were  	 VBD	O
assessed  	assessed  	 VBN	O
with  	with  	 IN	O
uPA  	uPA  	 JJ	O
and  	and  	 CC	O
S-2444 	S-2444 	 NNP	B-NP
.  	.  	 .	O
As  	As  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Fg.  	Fg.  	 CD	B-NP
4A 	4A 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
Glu351Ala  	Glu351Ala  	 NNP	O
and  	and  	 CC	O
Glu351Arg  	Glu351Arg  	 CD	O
after  	after  	 IN	O
denatured  	denatured  	 NN	O
by  	by  	 IN	O
6  	6  	 CD	O
M  	M  	 NNP	O
Gdn-HCl  	Gdn-HCl  	 NNP	B-NP
and  	and  	 CC	O
dialyzed  	dialyzed  	 NN	B-NP
against  	against  	 IN	O
50  	50  	 CD	O
mM  	mM  	 JJ	O
sodium  	sodium  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
pH  	pH  	 JJ	O
5.6 	5.6 	 CD	O
,  	,  	 ,	O
was  	was  	 VBD	O
84  	84  	 CD	O
±  	±  	 CD	O
15 	15 	 CD	O
,  	,  	 ,	O
112  	112  	 CD	O
±  	±  	 CD	O
18  	18  	 CD	O
and  	and  	 CC	O
68  	68  	 CD	O
±  	±  	 CD	O
9  	9  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
ug 	ug 	 NN	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Glu351Ala  	Glu351Ala  	 NNP	O
had  	had  	 VBD	O
a  	a  	 DT	O
higher 	higher 	 JJR	O
,  	,  	 ,	O
and  	and  	 CC	O
Glu351Arg  	Glu351Arg  	 CD	O
lower  	lower  	 JJR	O
specific  	specific  	 JJ	O
activity  	activity  	 NN	O
than  	than  	 IN	O
wtPAI-1 	wtPAI-1 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
specific  	specific  	 JJ	O
activities  	activities  	 NNS	O
of  	of  	 IN	O
PAI-1s  	PAI-1s  	 NNP	B-NP
determined  	determined  	 VBD	O
immediately  	immediately  	 RB	O
after  	after  	 IN	O
purification  	purification  	 NN	B-NP
displayed  	displayed  	 VBD	O
similar  	similar  	 JJ	O
pattern  	pattern  	 NN	O
as  	as  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
inhibitors  	inhibitors  	 JJ	O
reactivated 	reactivated 	 NN	O
.  	.  	 .	O
There  	There  	 EX	O
was  	was  	 VBD	O
about  	about  	 IN	O
15-20 	15-20 	 CD	O
%  	%  	 NN	O
increase  	increase  	 NN	O
after  	after  	 IN	O
reactivation  	reactivation  	 VBG	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
each  	each  	 DT	O
untreated  	untreated  	 JJ	O
protein  	protein  	 NN	B-NP
itself 	itself 	 PRP	O
.  	.  	 .	O
As  	As  	 RB	O
shown  	shown  	 VBN	O
in  	in  	 IN	O
Fig.  	Fig.  	 CD	O
4B 	4B 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
two  	two  	 CD	O
mutants  	mutants  	 NNS	B-NP
also  	also  	 RB	O
spontaneously  	spontaneously  	 RB	O
lost  	lost  	 VBD	O
their  	their  	 PRP$	O
inhibitory  	inhibitory  	 JJ	B-NP
activity 	activity 	 NN	I-NP
( 	( 	 -LRB-	I-NP
convert  	convert  	 VB	I-NP
to  	to  	 TO	I-NP
latency 	latency 	 CD	I-NP
)  	)  	 -RRB-	I-NP
as  	as  	 IN	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
at  	at  	 IN	O
different  	different  	 JJ	O
rates 	rates 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
functional  	functional  	 JJ	B-NP
stability  	stability  	 NN	I-NP
of  	of  	 IN	I-NP
wtPAI-1 	wtPAI-1 	 NNP	I-NP
,  	,  	 ,	O
Glu351Ala 	Glu351Ala 	 NNP	O
,  	,  	 ,	O
Glu351Arg  	Glu351Arg  	 NNP	O
was  	was  	 VBD	O
about  	about  	 IN	O
18  	18  	 CD	O
±  	±  	 CD	O
5 	5 	 CD	O
,  	,  	 ,	O
90  	90  	 CD	O
±  	±  	 CD	O
8  	8  	 CD	O
and  	and  	 CC	O
14  	14  	 CD	O
±  	±  	 CD	O
3  	3  	 CD	O
minutes 	minutes 	 NNS	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
It  	It  	 PRP	O
suggested  	suggested  	 VBD	O
that  	that  	 IN	O
the  	the  	 DT	O
specific  	specific  	 JJ	O
activities  	activities  	 NNS	O
measured  	measured  	 VBN	O
above 	above 	 IN	O
,  	,  	 ,	O
to  	to  	 TO	O
some  	some  	 DT	O
extent 	extent 	 NN	O
,  	,  	 ,	O
proportionally  	proportionally  	 RB	O
represent  	represent  	 VB	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
stability 	stability 	 NN	I-NP
.  	.  	 .	O
More  	More  	 RBR	O
importantly 	importantly 	 RB	O
,  	,  	 ,	O
amount  	amount  	 NN	B-NP
complexes  	complexes  	 NNS	I-NP
formed  	formed  	 VBN	O
by  	by  	 IN	O
tPA  	tPA  	 JJ	O
and  	and  	 CC	O
PAI-1s  	PAI-1s  	 NNP	B-NP
remained  	remained  	 VBD	O
after  	after  	 IN	O
incubation  	incubation  	 NN	O
at  	at  	 IN	O
37°C  	37°C  	 NNP	O
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
4C 	4C 	 NNP	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
proportionally  	proportionally  	 JJ	O
concordant  	concordant  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
results  	results  	 NNS	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
enzymatic  	enzymatic  	 JJ	B-NP
stability  	stability  	 NN	I-NP
assay  	assay  	 NNS	I-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
4B 	4B 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
proves  	proves  	 NN	O
that  	that  	 IN	O
results  	results  	 NNS	O
from  	from  	 IN	O
enzymatic  	enzymatic  	 JJ	B-NP
assay  	assay  	 NNS	I-NP
are  	are  	 VBP	O
valid 	valid 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
result  	result  	 NN	O
of  	of  	 IN	O
functional  	functional  	 JJ	B-NP
stability  	stability  	 NN	I-NP
suggests  	suggests  	 VBZ	O
that  	that  	 IN	O
Glu351  	Glu351  	 NNP	B-NP
is  	is  	 VBZ	O
indeed  	indeed  	 RB	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
conformational  	conformational  	 JJ	B-NP
transition  	transition  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1 	PAI-1 	 CD	I-NP
.  	.  	 .	O
Inhibition  	Inhibition  	 NNP	O
of  	of  	 IN	O
thrombin  	thrombin  	 NN	B-NP
by  	by  	 IN	O
PAI-1s  	PAI-1s  	 NNP	B-NP
and  	and  	 CC	O
Neutralization  	Neutralization  	 NNP	B-NP
of  	of  	 IN	I-NP
PAI-1s  	PAI-1s  	 CD	I-NP
by  	by  	 IN	O
Thrombin  	Thrombin  	 NNP	B-NP
Both  	Both  	 DT	O
mutants  	mutants  	 JJ	B-NP
inhibited  	inhibited  	 JJ	I-NP
thrombin  	thrombin  	 NN	I-NP
more  	more  	 RBR	O
efficiently  	efficiently  	 RB	O
than  	than  	 IN	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
more  	more  	 RBR	O
importantly 	importantly 	 RB	O
,  	,  	 ,	O
Glu351Ala  	Glu351Ala  	 NNP	O
was  	was  	 VBD	O
better  	better  	 JJR	O
than  	than  	 IN	O
Glu351Arg  	Glu351Arg  	 CD	O
in  	in  	 IN	O
inhibiting  	inhibiting  	 JJ	O
thrombin  	thrombin  	 NNS	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
5A 	5A 	 NNP	O
) 	) 	 -RRB-	O
;  	;  	 :	O
Inhibition  	Inhibition  	 NNP	O
of  	of  	 IN	O
thrombin  	thrombin  	 NN	B-NP
by  	by  	 IN	O
Glu351Arg  	Glu351Arg  	 NNP	O
was  	was  	 VBD	O
almost  	almost  	 RB	O
as  	as  	 IN	O
same  	same  	 JJ	O
as  	as  	 IN	O
by  	by  	 IN	O
Glu351Ala  	Glu351Ala  	 CD	O
in  	in  	 IN	O
presence  	presence  	 NN	O
of  	of  	 IN	O
vitronectin  	vitronectin  	 NNS	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
5B 	5B 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
which  	which  	 WDT	O
facilitated  	facilitated  	 VBZ	O
the  	the  	 DT	O
thrombin  	thrombin  	 JJ	B-NP
inhibition  	inhibition  	 NN	I-NP
by  	by  	 IN	O
both  	both  	 DT	O
mutants 	mutants 	 NN	B-NP
.  	.  	 .	O
When  	When  	 WRB	O
excess  	excess  	 JJ	O
equal  	equal  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
thrombin  	thrombin  	 NN	B-NP
was  	was  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
equal  	equal  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
PAI-1s  	PAI-1s  	 CD	B-NP
in  	in  	 IN	O
term  	term  	 NN	O
of  	of  	 IN	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
against  	against  	 IN	O
uPA 	uPA 	 NNP	B-NP
,  	,  	 ,	O
mutant  	mutant  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
were  	were  	 VBD	O
neutralized  	neutralized  	 VBN	O
faster  	faster  	 RBR	O
by  	by  	 IN	O
thrombin  	thrombin  	 NN	B-NP
than  	than  	 IN	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
vitronectin  	vitronectin  	 VBP	O
also  	also  	 RB	O
facilitated  	facilitated  	 VB	O
the  	the  	 DT	O
neutralization  	neutralization  	 NN	B-NP
of  	of  	 IN	O
Glu351Ala  	Glu351Ala  	 NNP	O
or  	or  	 CC	O
Glu351Arg  	Glu351Arg  	 CD	O
by  	by  	 IN	O
thrombin 	thrombin 	 NN	B-NP
,  	,  	 ,	O
just  	just  	 RB	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 NNP	O
5C 	5C 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Inhibition  	Inhibition  	 NNP	O
of  	of  	 IN	O
plasmin  	plasmin  	 NN	B-NP
by  	by  	 IN	O
PAI-1s  	PAI-1s  	 CD	B-NP
When  	When  	 WRB	O
plasmin  	plasmin  	 NNS	B-NP
was  	was  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
increased  	increased  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
equal  	equal  	 JJ	O
active  	active  	 JJ	O
PAI-1s  	PAI-1s  	 NN	B-NP
in  	in  	 IN	O
absence  	absence  	 NN	B-NP
or  	or  	 CC	O
in  	in  	 IN	O
presence  	presence  	 NN	O
of  	of  	 IN	O
vitronectin 	vitronectin 	 NN	B-NP
,  	,  	 ,	O
it  	it  	 PRP	O
was  	was  	 VBD	O
inhibited  	inhibited  	 VBN	O
faster  	faster  	 RBR	O
by  	by  	 IN	O
mutants  	mutants  	 NN	B-NP
than  	than  	 IN	O
by  	by  	 IN	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
6upper  	6upper  	 CD	O
panel 	panel 	 NN	O
) 	) 	 -RRB-	O
;  	;  	 :	O
and  	and  	 CC	O
both  	both  	 DT	O
of  	of  	 IN	O
mutant  	mutant  	 VBG	O
also  	also  	 RB	O
displayed  	displayed  	 VBN	O
improved  	improved  	 JJ	O
inhibition  	inhibition  	 NN	O
toward  	toward  	 IN	O
plasmin  	plasmin  	 NN	B-NP
in  	in  	 IN	O
presence  	presence  	 NN	O
of  	of  	 IN	O
vitronectin  	vitronectin  	 NNS	B-NP
( 	( 	 -LRB-	O
Fig.  	Fig.  	 CD	O
6lower  	6lower  	 CD	O
panel 	panel 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Kinetic  	Kinetic  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
The  	The  	 DT	O
rate  	rate  	 NN	B-NP
constants  	constants  	 NN	I-NP
of  	of  	 IN	O
tPA  	tPA  	 JJ	O
for  	for  	 IN	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
Glu351Ala  	Glu351Ala  	 NNP	O
and  	and  	 CC	O
Glu351Arg  	Glu351Arg  	 NNP	O
were  	were  	 VBD	O
similar  	similar  	 JJ	O
( 	( 	 -LRB-	O
Table  	Table  	 NNP	O
4 	4 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
The  	The  	 DT	O
rate  	rate  	 NN	B-NP
constants  	constants  	 NN	I-NP
of  	of  	 IN	O
inhibition  	inhibition  	 NN	O
toward  	toward  	 IN	O
uPA  	uPA  	 JJ	O
by  	by  	 IN	O
Glu351Ala  	Glu351Ala  	 NNP	O
and  	and  	 CC	O
Glu351Arg  	Glu351Arg  	 NNP	O
were  	were  	 VBD	O
4  	4  	 CD	O
and  	and  	 CC	O
7-fold  	7-fold  	 CD	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
by  	by  	 IN	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
The  	The  	 DT	O
rate  	rate  	 NN	B-NP
constants  	constants  	 NN	I-NP
of  	of  	 IN	O
Glu351Ala  	Glu351Ala  	 NNP	O
and  	and  	 CC	O
Glu351Arg  	Glu351Arg  	 CD	O
for  	for  	 IN	O
thrombin  	thrombin  	 JJ	B-NP
inhibition  	inhibition  	 NN	I-NP
were  	were  	 VBD	O
2  	2  	 CD	O
to  	to  	 TO	O
4  	4  	 CD	O
folds  	folds  	 CD	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
and  	and  	 CC	O
rate  	rate  	 NN	B-NP
constants  	constants  	 NN	I-NP
of  	of  	 IN	O
Glu351Ala  	Glu351Ala  	 NNP	O
and  	and  	 CC	O
Glu351Arg  	Glu351Arg  	 CD	O
to  	to  	 TO	O
plasmin  	plasmin  	 NNS	B-NP
were  	were  	 VBD	O
2  	2  	 CD	O
fold  	fold  	 CD	O
higher  	higher  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
wtPAI-1 	wtPAI-1 	 CD	B-NP
.  	.  	 .	O
This  	This  	 DT	O
indicates  	indicates  	 VBZ	O
that  	that  	 IN	O
Glu351  	Glu351  	 NNP	B-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
essential  	essential  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
tPA 	tPA 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
an  	an  	 DT	O
very  	very  	 RB	O
important  	important  	 JJ	O
determinant  	determinant  	 NN	B-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
optimal  	optimal  	 JJ	I-NP
interaction  	interaction  	 NN	I-NP
with  	with  	 IN	O
uPA 	uPA 	 NNP	B-NP
,  	,  	 ,	O
thrombin  	thrombin  	 NN	B-NP
and  	and  	 CC	O
plasmin 	plasmin 	 NN	B-NP
.  	.  	 .	O
Disscusion  	Disscusion  	 FW	O
Cognate  	Cognate  	 FW	B-NP
protease  	protease  	 FW	I-NP
specificity  	specificity  	 FW	I-NP
Improvements  	Improvements  	 NNP	I-NP
in  	in  	 IN	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
mutants  	mutants  	 NN	B-NP
for  	for  	 IN	I-NP
uPA  	uPA  	 NNP	I-NP
indicates  	indicates  	 VBZ	O
that  	that  	 IN	O
Glu351  	Glu351  	 CD	B-NP
involve  	involve  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
uPA 	uPA 	 JJ	O
.  	.  	 .	O
To  	To  	 TO	O
the  	the  	 DT	O
best  	best  	 JJS	O
of  	of  	 IN	O
our  	our  	 PRP$	O
knowledge 	knowledge 	 NN	O
,  	,  	 ,	O
this  	this  	 DT	O
is  	is  	 VBZ	O
the  	the  	 DT	O
first  	first  	 JJ	O
time  	time  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
PAI-1  	PAI-1  	 CD	B-NP
toward  	toward  	 IN	O
uPA  	uPA  	 NNP	B-NP
is  	is  	 VBZ	O
partially  	partially  	 RB	O
mediated  	mediated  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
negatively  	negatively  	 RB	O
charged  	charged  	 VBN	O
residue  	residue  	 RB	O
located  	located  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
C-terminal  	C-terminal  	 JJ	B-NP
of  	of  	 IN	O
cleavage  	cleavage  	 JJ	O
site  	site  	 NN	O
in  	in  	 IN	O
PAI-1 	PAI-1 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
Glu351  	Glu351  	 CD	B-NP
with  	with  	 IN	O
uPA  	uPA  	 NNP	B-NP
is  	is  	 VBZ	O
much  	much  	 RB	O
more  	more  	 RBR	O
important  	important  	 JJ	O
than  	than  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
Glu351  	Glu351  	 CD	B-NP
with  	with  	 IN	O
tPA 	tPA 	 NNP	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
is  	is  	 VBZ	O
demonstrated  	demonstrated  	 VBN	O
by  	by  	 IN	O
improved  	improved  	 JJ	O
reactivity  	reactivity  	 NN	B-NP
of  	of  	 IN	I-NP
Glu351  	Glu351  	 CD	I-NP
mutants  	mutants  	 NN	I-NP
toward  	toward  	 IN	O
uPA 	uPA 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
toward  	toward  	 IN	O
tPA 	tPA 	 NNP	B-NP
,  	,  	 ,	O
showing  	showing  	 VBG	O
that  	that  	 IN	O
tPA  	tPA  	 NNP	B-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
directly  	directly  	 RB	O
interact  	interact  	 VBN	O
with  	with  	 IN	O
Glu351  	Glu351  	 CD	B-NP
of  	of  	 IN	I-NP
PAI-1 	PAI-1 	 NNP	I-NP
,  	,  	 ,	O
whereas  	whereas  	 IN	O
Glu351  	Glu351  	 NNP	B-NP
is  	is  	 VBZ	O
necessary  	necessary  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
optimal  	optimal  	 JJ	B-NP
interaction  	interaction  	 NN	I-NP
with  	with  	 IN	O
uPA 	uPA 	 JJ	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
are  	are  	 VBP	O
concordant  	concordant  	 VBN	O
with  	with  	 IN	O
previous  	previous  	 JJ	O
study 	study 	 NN	O
,  	,  	 ,	O
[  	[  	 -LRB-	O
25  	25  	 CD	O
]  	]  	 -RRB-	O
which  	which  	 WDT	O
suggests  	suggests  	 VBZ	O
that  	that  	 DT	O
serpin  	serpin  	 JJ	B-NP
body-protease  	body-protease  	 JJ	I-NP
body  	body  	 NN	I-NP
interactions  	interactions  	 NNS	I-NP
play  	play  	 VBP	O
significant  	significant  	 JJ	O
roles  	roles  	 NNS	O
in  	in  	 IN	O
determining  	determining  	 VBG	O
serpin  	serpin  	 JJ	B-NP
inhibitory  	inhibitory  	 JJ	I-NP
activity  	activity  	 NN	I-NP
against  	against  	 IN	O
target  	target  	 NN	B-NP
proteases 	proteases 	 NN	I-NP
.  	.  	 .	O
Non-cognate  	Non-cognate  	 JJ	B-NP
protease  	protease  	 JJ	I-NP
Substitution  	Substitution  	 NNS	I-NP
of  	of  	 IN	O
Glu351  	Glu351  	 NNP	B-NP
also  	also  	 RB	O
altered  	altered  	 VBN	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
toward  	toward  	 IN	O
non-cognate  	non-cognate  	 JJ	B-NP
proteases 	proteases 	 NN	I-NP
:  	:  	 :	O
plasmin  	plasmin  	 NNS	B-NP
and  	and  	 CC	O
thrombin 	thrombin 	 NN	B-NP
.  	.  	 .	O
Glu  	Glu  	 NNP	B-NP
at  	at  	 IN	O
351  	351  	 CD	O
may  	may  	 MD	O
provide  	provide  	 VB	O
steric  	steric  	 JJ	B-NP
hindrance  	hindrance  	 NN	I-NP
that  	that  	 WDT	O
slows  	slows  	 VBZ	O
the  	the  	 DT	O
rate  	rate  	 NN	O
of  	of  	 IN	O
thrombin  	thrombin  	 NN	B-NP
or  	or  	 CC	O
plasmin  	plasmin  	 JJ	B-NP
inhibition 	inhibition 	 NN	I-NP
.  	.  	 .	O
Mutations  	Mutations  	 NNS	O
at  	at  	 IN	O
Glu351  	Glu351  	 NNP	B-NP
may  	may  	 MD	O
decrease  	decrease  	 VB	O
the  	the  	 DT	O
original  	original  	 JJ	B-NP
repulsive  	repulsive  	 JJ	I-NP
interactions  	interactions  	 NNS	I-NP
with  	with  	 IN	O
variable  	variable  	 JJ	O
region  	region  	 NN	O
of  	of  	 IN	O
thrombin 	thrombin 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
may  	may  	 MD	O
slow  	slow  	 VB	O
the  	the  	 DT	O
rate  	rate  	 NN	O
of  	of  	 IN	O
thrombin  	thrombin  	 JJ	B-NP
inhibition 	inhibition 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
results  	results  	 NNS	O
in  	in  	 IN	O
favorable  	favorable  	 JJ	O
interactions  	interactions  	 NNS	B-NP
that  	that  	 WDT	O
may  	may  	 MD	O
not  	not  	 RB	O
exist  	exist  	 VB	O
when  	when  	 WRB	O
wtPAI-1  	wtPAI-1  	 RB	B-NP
react  	react  	 VB	O
with  	with  	 IN	O
thrombin 	thrombin 	 NN	B-NP
.  	.  	 .	O
So 	So 	 RB	O
,  	,  	 ,	O
both  	both  	 DT	O
Glu351Arg  	Glu351Arg  	 NNP	O
and  	and  	 CC	O
Glu351Arg  	Glu351Arg  	 NNP	O
are  	are  	 VBP	O
better  	better  	 RBR	O
thrombin  	thrombin  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
than  	than  	 IN	O
wtPAI-1 	wtPAI-1 	 CD	B-NP
.  	.  	 .	O
Similar  	Similar  	 JJ	B-NP
results  	results  	 NNS	I-NP
were  	were  	 VBD	O
observed  	observed  	 VBN	O
for  	for  	 IN	O
plasmin 	plasmin 	 NN	B-NP
.  	.  	 .	O
With  	With  	 IN	O
single  	single  	 JJ	O
mutation  	mutation  	 NN	O
at  	at  	 IN	O
position  	position  	 NN	B-NP
Glu351 	Glu351 	 NN	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
improved  	improved  	 VBD	O
reactivity  	reactivity  	 VBN	O
of  	of  	 IN	O
PAI-1  	PAI-1  	 CD	B-NP
to  	to  	 TO	O
thrombin  	thrombin  	 VB	O
and  	and  	 CC	O
plasmin  	plasmin  	 NN	B-NP
without  	without  	 IN	O
significantly  	significantly  	 RB	O
affecting  	affecting  	 VBG	O
its  	its  	 PRP$	O
specificity  	specificity  	 NN	O
to  	to  	 TO	O
tPA 	tPA 	 JJ	O
.  	.  	 .	O
This  	This  	 DT	O
substantiates  	substantiates  	 JJ	O
previous  	previous  	 JJ	O
mutagenesis  	mutagenesis  	 JJ	B-NP
studies 	studies 	 NNS	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
demonstrated  	demonstrated  	 VBD	O
that  	that  	 DT	O
repulsive  	repulsive  	 JJ	B-NP
interactions  	interactions  	 NNS	I-NP
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
lack  	lack  	 NN	O
of  	of  	 IN	O
productive  	productive  	 JJ	B-NP
electrostatic  	electrostatic  	 JJ	I-NP
interactions  	interactions  	 NNS	I-NP
between  	between  	 IN	O
Glu39  	Glu39  	 NNP	B-NP
and  	and  	 CC	O
Glu192  	Glu192  	 CD	B-NP
of  	of  	 IN	I-NP
thrombin  	thrombin  	 NN	I-NP
and  	and  	 CC	O
PAI-1  	PAI-1  	 NNP	B-NP
are  	are  	 VBP	O
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
slow  	slow  	 JJ	O
reaction  	reaction  	 NN	O
of  	of  	 IN	O
thrombin  	thrombin  	 NN	B-NP
with  	with  	 IN	O
this  	this  	 DT	O
serpin.  	serpin.  	 NNP	B-NP
[  	[  	 -LRB-	O
26  	26  	 CD	O
]  	]  	 -RRB-	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
rapid  	rapid  	 JJ	B-NP
inhibition  	inhibition  	 NN	I-NP
of  	of  	 IN	I-NP
plasmin  	plasmin  	 NN	I-NP
requires  	requires  	 VBZ	O
a  	a  	 DT	O
non-covalent  	non-covalent  	 JJ	B-NP
interaction  	interaction  	 NN	I-NP
between  	between  	 IN	O
an  	an  	 DT	O
amino-terminal  	amino-terminal  	 JJ	B-NP
site  	site  	 NN	I-NP
of  	of  	 IN	I-NP
plasmin  	plasmin  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
carboxyl-terminal  	carboxyl-terminal  	 JJ	B-NP
on  	on  	 IN	O
anti-plasmin 	anti-plasmin 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
a  	a  	 DT	O
second  	second  	 JJ	O
site  	site  	 NN	O
outside  	outside  	 IN	O
the  	the  	 DT	O
RCL  	RCL  	 NNP	B-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
contributes  	contributes  	 VBZ	O
to  	to  	 TO	O
its  	its  	 PRP$	O
specific  	specific  	 JJ	O
interaction  	interaction  	 NN	O
with  	with  	 IN	O
proteases.  	proteases.  	 NNP	B-NP
[  	[  	 -LRB-	O
15  	15  	 CD	O
27  	27  	 CD	O
]  	]  	 -RRB-	O
The  	The  	 DT	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
two  	two  	 CD	O
mutants  	mutants  	 NN	B-NP
toward  	toward  	 IN	O
thrombin  	thrombin  	 NN	B-NP
and  	and  	 CC	O
plasmin  	plasmin  	 JJ	O
implicates  	implicates  	 NN	O
that  	that  	 IN	O
Glu351  	Glu351  	 CD	B-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
is  	is  	 VBZ	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
its  	its  	 PRP$	O
specificity  	specificity  	 NN	O
toward  	toward  	 IN	O
thrombin  	thrombin  	 NN	B-NP
and  	and  	 CC	O
plasmin 	plasmin 	 NN	B-NP
.  	.  	 .	O
Conclusion  	Conclusion  	 NNP	B-NP
Single  	Single  	 NNP	I-NP
site  	site  	 NN	I-NP
mutations  	mutations  	 NNS	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
segment  	segment  	 NN	B-NP
Asp355-Arg356-Pro357  	Asp355-Arg356-Pro357  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 CD	I-NP
yield  	yield  	 NN	I-NP
Gdn-HCl  	Gdn-HCl  	 JJ	I-NP
activatable  	activatable  	 JJ	I-NP
inhibitors  	inhibitors  	 NN	I-NP
that  	that  	 WDT	O
can  	can  	 MD	O
still  	still  	 RB	O
form  	form  	 VB	O
SDS  	SDS  	 JJ	B-NP
stable  	stable  	 JJ	I-NP
complexes  	complexes  	 NNS	I-NP
with  	with  	 IN	O
plasminogen  	plasminogen  	 JJ	B-NP
activators 	activators 	 NN	I-NP
,  	,  	 ,	O
with  	with  	 IN	O
second  	second  	 JJ	O
order  	order  	 NN	B-NP
inhibition  	inhibition  	 NN	I-NP
constants  	constants  	 NNS	I-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
similar  	similar  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
native  	native  	 JJ	O
inhibitor 	inhibitor 	 NN	O
.  	.  	 .	O
Interestingly 	Interestingly 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
conversion  	conversion  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
mutants  	mutants  	 NN	B-NP
to  	to  	 TO	O
latent  	latent  	 VB	O
forms  	forms  	 NNS	O
was  	was  	 VBD	O
~3-4  	~3-4  	 RB	O
fold  	fold  	 VB	O
faster  	faster  	 RBR	O
than  	than  	 IN	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
suggesting  	suggesting  	 VBG	O
that  	that  	 IN	O
the  	the  	 DT	O
Asp355-Pro357  	Asp355-Pro357  	 JJ	B-NP
segment  	segment  	 NN	I-NP
is  	is  	 VBZ	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
maintaining  	maintaining  	 VBG	O
the  	the  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
conformation  	conformation  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1 	PAI-1 	 CD	I-NP
.  	.  	 .	O
Glu351  	Glu351  	 NNP	B-NP
contributes  	contributes  	 VBZ	O
to  	to  	 TO	O
the  	the  	 DT	O
optimal  	optimal  	 JJ	B-NP
functional  	functional  	 JJ	I-NP
stability  	stability  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
and  	and  	 CC	O
participates  	participates  	 VBZ	O
its  	its  	 PRP$	O
conformational  	conformational  	 JJ	B-NP
stability 	stability 	 NN	I-NP
.  	.  	 .	O
More  	More  	 RBR	O
importantly 	importantly 	 RB	O
,  	,  	 ,	O
Glu351  	Glu351  	 NNP	B-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
specificity  	specificity  	 JJ	B-NP
determinant  	determinant  	 NN	I-NP
for  	for  	 IN	I-NP
uPA 	uPA 	 NNP	I-NP
,  	,  	 ,	O
thrombin  	thrombin  	 NN	B-NP
and  	and  	 CC	O
plasmin 	plasmin 	 NN	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
for  	for  	 IN	O
tPA 	tPA 	 JJ	O
.  	.  	 .	O
Methods  	Methods  	 NNP	O
General  	General  	 NNP	B-NP
DNA  	DNA  	 NNP	I-NP
techniques  	techniques  	 NNS	I-NP
Plasmid  	Plasmid  	 NNP	I-NP
DNA  	DNA  	 NNP	I-NP
was  	was  	 VBD	O
purified  	purified  	 VBN	O
using  	using  	 VBG	O
either  	either  	 DT	O
Promega  	Promega  	 NNP	B-NP
or  	or  	 CC	O
QIAGEN  	QIAGEN  	 NNP	B-NP
miniprep  	miniprep  	 NN	I-NP
kits 	kits 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
DNA  	DNA  	 NN	B-NP
was  	was  	 VBD	O
sequenced  	sequenced  	 VBN	O
using  	using  	 VBG	O
the  	the  	 DT	O
di-deoxy  	di-deoxy  	 JJ	B-NP
chain  	chain  	 NN	I-NP
termination  	termination  	 NN	I-NP
reaction  	reaction  	 NN	I-NP
method  	method  	 NN	I-NP
using  	using  	 VBG	O
an  	an  	 DT	O
ABI  	ABI  	 NNP	B-NP
373  	373  	 CD	O
DNA  	DNA  	 NN	B-NP
sequencer 	sequencer 	 NN	I-NP
.  	.  	 .	O
Oligonucleotides  	Oligonucleotides  	 NNP	B-NP
were  	were  	 VBD	O
synthesized  	synthesized  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
380  	380  	 CD	O
B  	B  	 NNP	B-NP
DNA  	DNA  	 NNP	I-NP
synthesizer  	synthesizer  	 NNS	I-NP
( 	( 	 -LRB-	O
ABI  	ABI  	 NNP	B-NP
model 	model 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
DNA  	DNA  	 NNP	B-NP
manipulation  	manipulation  	 NN	I-NP
techniques  	techniques  	 NNS	I-NP
were  	were  	 VBD	O
carried  	carried  	 VBN	O
out  	out  	 RP	O
according  	according  	 VBG	O
to  	to  	 TO	O
standard  	standard  	 JJ	O
procedures  	procedures  	 NNS	O
[  	[  	 -LRB-	O
29  	29  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Construction  	Construction  	 NN	B-NP
of  	of  	 IN	I-NP
wtPAI-1  	wtPAI-1  	 NNP	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
mutants  	mutants  	 NNS	B-NP
The  	The  	 DT	O
pPAI-1-AI  	pPAI-1-AI  	 NNP	B-NP
was  	was  	 VBD	O
digested  	digested  	 VBN	O
with  	with  	 IN	O
EcoRI  	EcoRI  	 JJ	O
and  	and  	 CC	O
BglII  	BglII  	 JJ	O
to  	to  	 TO	O
release  	release  	 VB	O
a  	a  	 DT	O
1426  	1426  	 CD	O
basepair  	basepair  	 NNS	B-NP
( 	( 	 -LRB-	O
bp 	bp 	 LS	B-NP
)  	)  	 -RRB-	O
PAI-1  	PAI-1  	 FW	B-NP
coding  	coding  	 FW	O
sequence 	sequence 	 FW	O
,  	,  	 ,	O
which  	which  	 WDT	O
was  	was  	 VBD	O
isolated 	isolated 	 VBN	O
,  	,  	 ,	O
purified 	purified 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
ligated  	ligated  	 NN	O
into  	into  	 IN	O
EcoRI  	EcoRI  	 JJ	O
and  	and  	 CC	O
BglII  	BglII  	 JJ	B-NP
digested  	digested  	 JJ	I-NP
pVL1393 	pVL1393 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
resultant  	resultant  	 JJ	O
pVL1393-PAI-1  	pVL1393-PAI-1  	 NN	B-NP
was  	was  	 VBD	O
analyzed  	analyzed  	 VBN	O
by  	by  	 IN	O
restriction  	restriction  	 NN	B-NP
mapping  	mapping  	 NN	I-NP
and  	and  	 CC	O
sequencing 	sequencing 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
mutants  	mutants  	 NN	B-NP
at  	at  	 IN	O
E351A 	E351A 	 NNP	O
,  	,  	 ,	O
E351R 	E351R 	 NNP	O
,  	,  	 ,	O
D355 	D355 	 NNP	B-NP
,  	,  	 ,	O
R356 	R356 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
P357  	P357  	 CD	B-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
were  	were  	 VBD	O
generated  	generated  	 VBN	O
by  	by  	 IN	O
PCR 	PCR 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
occurrence  	occurrence  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
resulting  	resulting  	 VBG	B-NP
mutations  	mutations  	 JJ	I-NP
D355A 	D355A 	 NN	O
,  	,  	 ,	O
D355E 	D355E 	 NNP	O
,  	,  	 ,	O
D355H 	D355H 	 NNP	O
,  	,  	 ,	O
D355K 	D355K 	 NNP	O
,  	,  	 ,	O
D355N 	D355N 	 NNP	O
,  	,  	 ,	O
D355P 	D355P 	 NNP	O
,  	,  	 ,	O
D355Q 	D355Q 	 NNP	O
,  	,  	 ,	O
R356P 	R356P 	 NNP	O
,  	,  	 ,	O
P357G  	P357G  	 NNP	O
as  	as  	 IN	O
well  	well  	 RB	O
as  	as  	 IN	O
E351A  	E351A  	 NNP	O
and  	and  	 CC	O
E351R  	E351R  	 CD	O
in  	in  	 IN	O
pRSET  	pRSET  	 NNP	B-NP
was  	was  	 VBD	O
confirmed  	confirmed  	 VBN	O
by  	by  	 IN	O
sequencing 	sequencing 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
PAI-1  	PAI-1  	 JJ	B-NP
sequence  	sequence  	 NN	I-NP
containing  	containing  	 VBG	O
the  	the  	 DT	O
desired  	desired  	 JJ	O
mutations  	mutations  	 NNS	O
was  	was  	 VBD	O
digested  	digested  	 VBN	O
with  	with  	 IN	O
EcoR1  	EcoR1  	 NNP	B-NP
and  	and  	 CC	O
BglII 	BglII 	 JJ	O
,  	,  	 ,	O
and  	and  	 CC	O
then  	then  	 RB	O
subcloned  	subcloned  	 VBN	O
into  	into  	 IN	O
pVL1393 	pVL1393 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
recombinant  	recombinant  	 JJ	B-NP
baculoviruses  	baculoviruses  	 NNS	I-NP
containing  	containing  	 VBG	O
either  	either  	 DT	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
above  	above  	 JJ	O
mutants  	mutants  	 NN	B-NP
was  	was  	 VBD	O
obtained  	obtained  	 VBN	O
as  	as  	 IN	O
deccribed  	deccribed  	 NN	O
by  	by  	 IN	O
Kjoller  	Kjoller  	 NNP	B-NP
et  	et  	 FW	O
al.  	al.  	 FW	O
[  	[  	 -LRB-	O
30  	30  	 CD	O
]  	]  	 -RRB-	O
Expression  	Expression  	 NNP	O
and  	and  	 CC	O
purification  	purification  	 NN	B-NP
of  	of  	 IN	I-NP
wtPAI-1  	wtPAI-1  	 NNP	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
mutants  	mutants  	 JJ	O
High  	High  	 NNP	O
5  	5  	 CD	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
grown  	grown  	 VBN	O
at  	at  	 IN	O
27°C  	27°C  	 CD	O
in  	in  	 IN	O
SF-900  	SF-900  	 CD	B-NP
serum-free  	serum-free  	 JJ	I-NP
medium 	medium 	 NN	I-NP
,  	,  	 ,	O
were  	were  	 VBD	O
infected  	infected  	 VBN	O
with  	with  	 IN	O
high-titer  	high-titer  	 JJ	B-NP
virus  	virus  	 NN	I-NP
stocks  	stocks  	 NNS	I-NP
( 	( 	 -LRB-	O
1-3  	1-3  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
8 	8 	 CD	O
/ 	/ 	 CD	O
ml 	ml 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
medium  	medium  	 NN	O
was  	was  	 VBD	O
collected  	collected  	 VBN	O
48  	48  	 CD	O
hrs  	hrs  	 NN	B-NP
after  	after  	 IN	O
the  	the  	 DT	O
infection  	infection  	 NN	B-NP
( 	( 	 -LRB-	O
found  	found  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
the  	the  	 DT	O
optimal  	optimal  	 JJ	B-NP
harvesting  	harvesting  	 JJ	I-NP
time  	time  	 NN	I-NP
for  	for  	 IN	I-NP
wtPAI-1 	wtPAI-1 	 CD	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
then  	then  	 RB	O
centrifuged  	centrifuged  	 VBN	O
for  	for  	 IN	O
5  	5  	 CD	O
minutes  	minutes  	 NNS	O
( 	( 	 -LRB-	O
125  	125  	 CD	O
×  	×  	 CD	O
g 	g 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
supernatents  	supernatents  	 NN	B-NP
( 	( 	 -LRB-	O
50  	50  	 CD	O
ml 	ml 	 CD	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
collected  	collected  	 VBN	O
and  	and  	 CC	O
sodium  	sodium  	 JJ	B-NP
chloride  	chloride  	 NN	I-NP
( 	( 	 -LRB-	O
final  	final  	 JJ	B-NP
concentration  	concentration  	 NN	I-NP
0.25  	0.25  	 CD	O
M 	M 	 NNP	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
added 	added 	 VBN	O
.  	.  	 .	O
They  	They  	 PRP	O
were  	were  	 VBD	O
then  	then  	 RB	O
applied  	applied  	 VBN	O
on  	on  	 IN	O
a  	a  	 DT	O
heparin-Sepharose  	heparin-Sepharose  	 JJ	B-NP
column  	column  	 NN	I-NP
( 	( 	 -LRB-	O
bed  	bed  	 NN	O
volume  	volume  	 NN	O
5  	5  	 CD	O
ml 	ml 	 CD	O
)  	)  	 -RRB-	O
that  	that  	 WDT	O
was  	was  	 VBD	O
equilibrated  	equilibrated  	 JJ	O
and  	and  	 CC	O
run  	run  	 VB	O
( 	( 	 -LRB-	O
flow  	flow  	 NN	B-NP
rate  	rate  	 NN	I-NP
20  	20  	 CD	O
ml 	ml 	 CD	B-NP
/ 	/ 	 CD	I-NP
h 	h 	 CD	I-NP
)  	)  	 -RRB-	O
with  	with  	 IN	O
a  	a  	 DT	O
buffer  	buffer  	 NN	B-NP
consisted  	consisted  	 VBD	O
of  	of  	 IN	O
50  	50  	 CD	O
mM  	mM  	 JJ	O
sodium  	sodium  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
pH  	pH  	 JJ	O
5.6 	5.6 	 CD	O
,  	,  	 ,	O
containing  	containing  	 VBG	O
0.25  	0.25  	 CD	O
M  	M  	 NNP	O
NaCl  	NaCl  	 NNP	B-NP
and  	and  	 CC	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
Tween-20 	Tween-20 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
columns  	columns  	 NNS	O
were  	were  	 VBD	O
washed  	washed  	 VBN	O
and  	and  	 CC	O
the  	the  	 DT	O
PAI-1s  	PAI-1s  	 NNP	B-NP
were  	were  	 VBD	O
eluted  	eluted  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
40  	40  	 CD	O
ml  	ml  	 JJ	B-NP
gradient  	gradient  	 NN	I-NP
of  	of  	 IN	O
0.25  	0.25  	 CD	O
-  	-  	 :	O
1  	1  	 CD	O
M  	M  	 NNP	O
NaCl  	NaCl  	 NNP	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
buffer 	buffer 	 NN	B-NP
.  	.  	 .	O
SDS-PAGE 	SDS-PAGE 	 NNP	B-NP
,  	,  	 ,	O
immunoblotting  	immunoblotting  	 NN	B-NP
and  	and  	 CC	O
deglycosylation  	deglycosylation  	 NN	B-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 CD	I-NP
The  	The  	 DT	O
medium  	medium  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
infected  	infected  	 JJ	O
cells  	cells  	 NNS	O
and  	and  	 CC	O
the  	the  	 DT	O
elutent  	elutent  	 NN	B-NP
from  	from  	 IN	O
heparin-Sepharose  	heparin-Sepharose  	 NNP	B-NP
were  	were  	 VBD	O
separated  	separated  	 VBN	O
on  	on  	 IN	O
10 	10 	 CD	O
%  	%  	 NN	O
SDS-PAGE 	SDS-PAGE 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
monitored  	monitored  	 VBN	O
by  	by  	 IN	O
silver  	silver  	 JJ	B-NP
staining 	staining 	 NN	I-NP
.  	.  	 .	O
Fibrosarcoma  	Fibrosarcoma  	 NNP	B-NP
PAI-1  	PAI-1  	 NNP	I-NP
and  	and  	 CC	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
were  	were  	 VBD	O
transferred  	transferred  	 VBN	O
onto  	onto  	 IN	O
nitrocellulose  	nitrocellulose  	 JJ	B-NP
paper  	paper  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
proteins  	proteins  	 NNS	O
were  	were  	 VBD	O
revealed  	revealed  	 VBN	O
with  	with  	 IN	O
anti-human  	anti-human  	 JJ	B-NP
PAI-1  	PAI-1  	 CD	I-NP
monoclonal  	monoclonal  	 CD	I-NP
antibodies 	antibodies 	 NNS	I-NP
,  	,  	 ,	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
horseradish  	horseradish  	 JJ	B-NP
peroxidase  	peroxidase  	 NNS	I-NP
( 	( 	 -LRB-	O
HRP 	HRP 	 NNP	B-NP
)  	)  	 -RRB-	O
conjugated  	conjugated  	 JJ	O
rabbit  	rabbit  	 JJ	B-NP
anti-mouse  	anti-mouse  	 JJ	I-NP
antibody 	antibody 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
enhanced  	enhanced  	 JJ	B-NP
chemiluminescence  	chemiluminescence  	 NNS	I-NP
( 	( 	 -LRB-	O
ECL 	ECL 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
5  	5  	 CD	O
ug  	ug  	 NN	B-NP
of  	of  	 IN	I-NP
Fibrosarcoma  	Fibrosarcoma  	 NNP	I-NP
PAI-1 	PAI-1 	 NNP	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
was  	was  	 VBD	O
denatured  	denatured  	 VBN	O
by  	by  	 IN	O
boiling  	boiling  	 VBG	O
for  	for  	 IN	O
5  	5  	 CD	O
min  	min  	 NN	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
buffer  	buffer  	 NN	B-NP
consisted  	consisted  	 VBD	O
of  	of  	 IN	O
0.5 	0.5 	 CD	O
%  	%  	 NN	O
SDS 	SDS 	 NNP	B-NP
,  	,  	 ,	O
50  	50  	 CD	O
mM  	mM  	 JJ	B-NP
β-mercaptoethanol  	β-mercaptoethanol  	 JJ	I-NP
and  	and  	 CC	O
50  	50  	 CD	O
mM  	mM  	 JJ	B-NP
Tris-HCl 	Tris-HCl 	 NN	I-NP
,  	,  	 ,	O
pH  	pH  	 JJ	O
7.4 	7.4 	 CD	O
.  	.  	 .	O
They  	They  	 PRP	O
were  	were  	 VBD	O
then  	then  	 RB	O
digested  	digested  	 VBN	O
( 	( 	 -LRB-	O
18  	18  	 CD	O
hr 	hr 	 NN	B-NP
,  	,  	 ,	O
at  	at  	 IN	O
37°C 	37°C 	 CD	O
)  	)  	 -RRB-	O
with  	with  	 IN	O
0.5  	0.5  	 CD	O
units  	units  	 NNS	O
of  	of  	 IN	O
recombinant  	recombinant  	 JJ	B-NP
N-glycanase  	N-glycanase  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
2.5 	2.5 	 CD	O
%  	%  	 NN	O
NP-40 	NP-40 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
SDS-PAGE  	SDS-PAGE  	 JJ	B-NP
and  	and  	 CC	O
silver  	silver  	 JJ	B-NP
staining 	staining 	 NN	I-NP
.  	.  	 .	O
Protein  	Protein  	 NN	B-NP
concentrations  	concentrations  	 NNS	I-NP
were  	were  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
Bio-Rad  	Bio-Rad  	 JJ	B-NP
protein  	protein  	 NN	I-NP
assay  	assay  	 NN	I-NP
reagent 	reagent 	 NN	I-NP
.  	.  	 .	O
Functional  	Functional  	 JJ	B-NP
stability  	stability  	 NN	I-NP
of  	of  	 IN	I-NP
fibrosarcoma  	fibrosarcoma  	 CD	I-NP
PAI-1 	PAI-1 	 CD	I-NP
,  	,  	 ,	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
mutants  	mutants  	 NNS	B-NP
The  	The  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
activities  	activities  	 NNS	I-NP
of  	of  	 IN	I-NP
fibrosarcoma  	fibrosarcoma  	 CD	I-NP
PAI-1 	PAI-1 	 CD	I-NP
,  	,  	 ,	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
its  	its  	 PRP$	O
mutants  	mutants  	 NN	B-NP
were  	were  	 VBD	O
measured  	measured  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
direct  	direct  	 JJ	O
chromogenic  	chromogenic  	 NNS	B-NP
assay  	assay  	 VBP	O
using  	using  	 VBG	O
uPA  	uPA  	 JJ	O
( 	( 	 -LRB-	O
100  	100  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 CD	I-NP
ug 	ug 	 CD	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
its  	its  	 PRP$	O
substrate  	substrate  	 JJ	B-NP
S-2444  	S-2444  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
microtiter  	microtiter  	 JJ	B-NP
plate  	plate  	 NN	I-NP
as  	as  	 IN	O
described  	described  	 VBN	O
earlier  	earlier  	 RBR	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Briefly 	Briefly 	 RB	O
,  	,  	 ,	O
fibrosarcoma  	fibrosarcoma  	 CD	B-NP
PAI-1 	PAI-1 	 CD	I-NP
,  	,  	 ,	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
its  	its  	 PRP$	O
mutants  	mutants  	 NN	B-NP
were  	were  	 VBD	O
diluted  	diluted  	 VBN	O
1 	1 	 CD	O
: 	: 	 :	O
10  	10  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
activity  	activity  	 NN	O
measuring  	measuring  	 VBG	O
assay  	assay  	 JJ	B-NP
buffer  	buffer  	 NN	I-NP
( 	( 	 -LRB-	O
50  	50  	 CD	O
uM  	uM  	 JJ	B-NP
Tris-HCl 	Tris-HCl 	 NN	I-NP
,  	,  	 ,	O
pH  	pH  	 JJ	O
7.5 	7.5 	 CD	O
,  	,  	 ,	O
containing  	containing  	 VBG	O
0.15  	0.15  	 NNP	O
M  	M  	 NNP	O
NaCl  	NaCl  	 NNP	B-NP
and  	and  	 CC	O
100  	100  	 CD	O
ug 	ug 	 FW	B-NP
/ 	/ 	 FW	I-NP
ml  	ml  	 FW	I-NP
BSA 	BSA 	 FW	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
PAI-1  	PAI-1  	 CD	B-NP
samples  	samples  	 NNS	I-NP
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
or  	or  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
two  	two  	 CD	O
molar  	molar  	 JJ	B-NP
excess  	excess  	 NN	I-NP
of  	of  	 IN	I-NP
vitronectin  	vitronectin  	 NNS	I-NP
( 	( 	 -LRB-	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
PAI-1  	PAI-1  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
vitronectin 	vitronectin 	 CD	B-NP
)  	)  	 -RRB-	O
at  	at  	 IN	O
37°C 	37°C 	 CD	O
.  	.  	 .	O
At  	At  	 IN	O
the  	the  	 DT	O
times  	times  	 NNS	O
indicated 	indicated 	 VBD	O
,  	,  	 ,	O
aliquots  	aliquots  	 NN	B-NP
were  	were  	 VBD	O
removed  	removed  	 VBN	O
and  	and  	 CC	O
analyzed  	analyzed  	 VBD	O
immediately  	immediately  	 RB	O
for  	for  	 IN	O
their  	their  	 PRP$	O
inhibitory  	inhibitory  	 JJ	B-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
One  	One  	 CD	O
unit  	unit  	 NN	O
of  	of  	 IN	O
PAI-1  	PAI-1  	 CD	B-NP
activity  	activity  	 NN	I-NP
is  	is  	 VBZ	O
defined  	defined  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
amount  	amount  	 NN	O
that  	that  	 WDT	O
completely  	completely  	 RB	O
neutralizes  	neutralizes  	 CD	O
1  	1  	 CD	O
U  	U  	 NNP	O
of  	of  	 IN	O
uPA 	uPA 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
specific  	specific  	 JJ	O
activity  	activity  	 NN	O
obtained  	obtained  	 VBN	O
at  	at  	 IN	O
time  	time  	 NN	O
zero  	zero  	 NN	O
was  	was  	 VBD	O
assigned  	assigned  	 VBN	O
a  	a  	 DT	O
value  	value  	 NN	O
of  	of  	 IN	O
100 	100 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
Activation  	Activation  	 NNP	B-NP
of  	of  	 IN	I-NP
PAI-1  	PAI-1  	 NNP	I-NP
and  	and  	 CC	O
kinetic  	kinetic  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
Fibrosarcoma  	Fibrosarcoma  	 NNP	I-NP
PAI-1 	PAI-1 	 NNP	I-NP
,  	,  	 ,	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
or  	or  	 CC	O
its  	its  	 PRP$	O
mutants  	mutants  	 NN	B-NP
were  	were  	 VBD	O
denatured  	denatured  	 VBN	O
with  	with  	 IN	O
6  	6  	 CD	O
M  	M  	 NNP	O
guanidine-hydrochloride  	guanidine-hydrochloride  	 NNP	B-NP
( 	( 	 -LRB-	O
Gdn-HCl 	Gdn-HCl 	 NNP	B-NP
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
45  	45  	 CD	O
min  	min  	 NN	B-NP
at  	at  	 IN	O
37°C 	37°C 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
dialysis  	dialysis  	 NN	O
( 	( 	 -LRB-	O
4-16  	4-16  	 CD	O
hours  	hours  	 NNS	O
at  	at  	 IN	O
4°C 	4°C 	 CD	O
)  	)  	 -RRB-	O
against  	against  	 IN	O
50  	50  	 CD	O
mM  	mM  	 JJ	O
sodium  	sodium  	 JJ	B-NP
acetate 	acetate 	 NN	I-NP
,  	,  	 ,	O
pH  	pH  	 JJ	O
5.6 	5.6 	 CD	O
,  	,  	 ,	O
containing  	containing  	 VBG	O
0.5  	0.5  	 CD	O
M  	M  	 NNP	O
NaCl  	NaCl  	 NNP	B-NP
and  	and  	 CC	O
0.01 	0.01 	 CD	O
%  	%  	 NN	O
Tween-20 	Tween-20 	 NN	B-NP
.  	.  	 .	O
This  	This  	 DT	O
process  	process  	 NN	O
which  	which  	 WDT	O
PAI-1  	PAI-1  	 VBZ	B-NP
regained  	regained  	 VBN	O
its  	its  	 PRP$	O
activity  	activity  	 NN	O
is  	is  	 VBZ	O
called  	called  	 VBN	O
activation  	activation  	 VBN	O
by  	by  	 IN	O
Gdn-HCl 	Gdn-HCl 	 JJ	B-NP
.  	.  	 .	O
The  	The  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
PAI-1s  	PAI-1s  	 NNP	B-NP
was  	was  	 VBD	O
assayed  	assayed  	 VBN	O
immediately 	immediately 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
second-order  	second-order  	 JJ	B-NP
rate  	rate  	 NN	I-NP
constants  	constants  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
fibrosarcoma  	fibrosarcoma  	 JJ	B-NP
PAI-1 	PAI-1 	 NN	I-NP
,  	,  	 ,	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
or  	or  	 CC	O
the  	the  	 DT	O
indicated  	indicated  	 JJ	O
mutants  	mutants  	 NN	B-NP
with  	with  	 IN	O
single-chain  	single-chain  	 JJ	B-NP
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA  	uPA  	 NNP	B-NP
were  	were  	 VBD	O
determined  	determined  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
single-step  	single-step  	 JJ	B-NP
assay  	assay  	 NN	I-NP
as  	as  	 IN	O
previously  	previously  	 RB	O
described.  	described.  	 CD	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
Specific  	Specific  	 JJ	O
activity 	activity 	 NN	O
,  	,  	 ,	O
functional  	functional  	 JJ	B-NP
stability  	stability  	 NN	I-NP
and  	and  	 CC	O
complex  	complex  	 JJ	O
formation  	formation  	 NN	O
of  	of  	 IN	O
PAI-1s  	PAI-1s  	 CD	B-NP
The  	The  	 DT	O
inhibitory  	inhibitory  	 JJ	B-NP
activities  	activities  	 NNS	I-NP
of  	of  	 IN	I-NP
wtPAI-1  	wtPAI-1  	 NNP	I-NP
and  	and  	 CC	O
mutants  	mutants  	 NNS	B-NP
were  	were  	 VBD	O
measured  	measured  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
direct  	direct  	 JJ	O
chromogenic  	chromogenic  	 NNS	B-NP
assay  	assay  	 VBP	O
using  	using  	 VBG	O
uPA  	uPA  	 JJ	O
( 	( 	 -LRB-	O
100  	100  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 CD	I-NP
μg 	μg 	 CD	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
substrate  	substrate  	 CD	B-NP
S-2444.  	S-2444.  	 CD	I-NP
[  	[  	 -LRB-	O
17  	17  	 CD	O
]  	]  	 -RRB-	O
Briefly 	Briefly 	 NNP	O
,  	,  	 ,	O
serially  	serially  	 VBD	O
diluted  	diluted  	 VBN	B-NP
wtPAI-1 	wtPAI-1 	 NNP	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
mutants  	mutants  	 NNS	B-NP
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
equal  	equal  	 JJ	O
volume  	volume  	 NN	O
of  	of  	 IN	O
uPA  	uPA  	 NNP	B-NP
( 	( 	 -LRB-	O
50  	50  	 CD	O
μl 	μl 	 NN	B-NP
,  	,  	 ,	O
50  	50  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 CD	I-NP
ml 	ml 	 CD	I-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
30  	30  	 CD	O
min  	min  	 NN	B-NP
at  	at  	 IN	O
37°C 	37°C 	 NNP	O
,  	,  	 ,	O
followed  	followed  	 VBN	O
by  	by  	 IN	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	O
100  	100  	 CD	O
μl 	μl 	 NN	B-NP
,  	,  	 ,	O
0.5  	0.5  	 CD	O
mM  	mM  	 JJ	B-NP
S-2444 	S-2444 	 NN	I-NP
.  	.  	 .	O
Residual  	Residual  	 JJ	B-NP
uPA  	uPA  	 JJ	I-NP
activity  	activity  	 NN	I-NP
was  	was  	 VBD	O
quantitated  	quantitated  	 VBN	O
by  	by  	 IN	O
measuring  	measuring  	 VBG	O
the  	the  	 DT	O
change  	change  	 NN	O
in  	in  	 IN	O
absorbance  	absorbance  	 NN	B-NP
at  	at  	 IN	O
405  	405  	 CD	O
nm  	nm  	 NN	B-NP
with  	with  	 IN	O
ELISA  	ELISA  	 NNP	B-NP
reader 	reader 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
specific  	specific  	 JJ	O
activity  	activity  	 NN	O
of  	of  	 IN	O
PAI-1  	PAI-1  	 NNP	B-NP
was  	was  	 VBD	O
calculated  	calculated  	 VBN	O
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
amount  	amount  	 NN	O
of  	of  	 IN	O
uPA  	uPA  	 JJ	B-NP
inhibited  	inhibited  	 NN	I-NP
by  	by  	 IN	O
PAI-1 	PAI-1 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
assay  	assay  	 NN	B-NP
for  	for  	 IN	I-NP
PAI-1  	PAI-1  	 CD	I-NP
inhibitory  	inhibitory  	 JJ	I-NP
activity  	activity  	 NN	I-NP
toward  	toward  	 IN	O
two-chain  	two-chain  	 JJ	B-NP
tPA  	tPA  	 NN	I-NP
was  	was  	 VBD	O
the  	the  	 DT	O
same  	same  	 JJ	O
for  	for  	 IN	O
uPA  	uPA  	 JJ	O
except  	except  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
tPA  	tPA  	 JJ	O
and  	and  	 CC	O
S-2288 	S-2288 	 NNP	B-NP
.  	.  	 .	O
PAI-1  	PAI-1  	 NNP	B-NP
inhibitory  	inhibitory  	 JJ	I-NP
activity  	activity  	 NN	I-NP
is  	is  	 VBZ	O
expressed  	expressed  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
international  	international  	 JJ	O
units  	units  	 NNS	O
of  	of  	 IN	O
PAs  	PAs  	 JJ	B-NP
inhibited  	inhibited  	 NN	O
by  	by  	 IN	O
PAI-1 	PAI-1 	 CD	B-NP
.  	.  	 .	O
Specific  	Specific  	 JJ	O
activity  	activity  	 NN	O
of  	of  	 IN	O
uPA  	uPA  	 JJ	O
and  	and  	 CC	O
two-chain  	two-chain  	 JJ	B-NP
tPA  	tPA  	 NNS	I-NP
are  	are  	 VBP	O
100  	100  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
μg  	μg  	 NN	I-NP
and  	and  	 CC	O
764  	764  	 CD	O
U 	U 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
μg 	μg 	 NN	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
For  	For  	 IN	O
the  	the  	 DT	O
functional  	functional  	 JJ	B-NP
stability 	stability 	 NN	I-NP
,  	,  	 ,	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
mutants  	mutants  	 NNS	B-NP
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
37°C 	37°C 	 CD	O
.  	.  	 .	O
Aliquots  	Aliquots  	 NNP	B-NP
were  	were  	 VBD	O
taken  	taken  	 VBN	O
out  	out  	 RP	O
at  	at  	 IN	O
times  	times  	 NNS	O
indicated  	indicated  	 VBD	O
and  	and  	 CC	O
analyzed  	analyzed  	 VBD	O
immediately  	immediately  	 RB	O
as  	as  	 RB	O
described  	described  	 VBN	O
above 	above 	 IN	O
.  	.  	 .	O
The  	The  	 DT	O
specific  	specific  	 JJ	O
activity  	activity  	 NN	O
obtained  	obtained  	 VBN	O
at  	at  	 IN	O
time  	time  	 NN	O
zero  	zero  	 NN	O
was  	was  	 VBD	O
assigned  	assigned  	 VBN	O
a  	a  	 DT	O
value  	value  	 NN	O
of  	of  	 IN	O
100 	100 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
provide  	provide  	 VB	O
the  	the  	 DT	O
evidence  	evidence  	 NN	O
to  	to  	 TO	O
support  	support  	 VB	O
the  	the  	 DT	O
conclusion  	conclusion  	 NN	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
enzyme  	enzyme  	 JJ	B-NP
assay 	assay 	 NN	I-NP
,  	,  	 ,	O
certain  	certain  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
E351R  	E351R  	 NNP	O
and  	and  	 CC	O
E351A  	E351A  	 NNP	O
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
equal  	equal  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
tPA  	tPA  	 JJ	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
30  	30  	 CD	O
minutes  	minutes  	 NNS	O
before  	before  	 IN	O
put  	put  	 VBN	O
on  	on  	 IN	O
ice 	ice 	 NN	O
,  	,  	 ,	O
at  	at  	 IN	O
same  	same  	 JJ	O
time  	time  	 NN	O
these  	these  	 DT	O
PAI-1s  	PAI-1s  	 NNP	B-NP
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
in  	in  	 IN	O
PBS  	PBS  	 NNP	B-NP
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
3  	3  	 CD	O
hours 	hours 	 NNS	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
,  	,  	 ,	O
before  	before  	 IN	O
the  	the  	 DT	O
PAI-1s  	PAI-1s  	 NNP	B-NP
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
same  	same  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
tPA  	tPA  	 JJ	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
30  	30  	 CD	O
minutes 	minutes 	 NNS	O
,  	,  	 ,	O
then  	then  	 RB	O
the  	the  	 DT	O
protein  	protein  	 NN	B-NP
samples  	samples  	 NNS	I-NP
prepared  	prepared  	 VBN	O
at  	at  	 IN	O
two  	two  	 CD	O
time  	time  	 NN	B-NP
points  	points  	 NNS	I-NP
were  	were  	 VBD	O
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
SDS-PAGE  	SDS-PAGE  	 JJ	B-NP
and  	and  	 CC	O
western  	western  	 JJ	O
blot  	blot  	 NN	O
as  	as  	 IN	O
described  	described  	 VBN	O
before 	before 	 RB	O
.  	.  	 .	O
Inhibition  	Inhibition  	 NNP	O
of  	of  	 IN	O
thrombin  	thrombin  	 NN	B-NP
and  	and  	 CC	O
plasmin  	plasmin  	 NN	B-NP
by  	by  	 IN	O
PAI-1s  	PAI-1s  	 NNP	B-NP
Thrombin  	Thrombin  	 NNP	I-NP
( 	( 	 -LRB-	O
0.025  	0.025  	 NNP	O
U 	U 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
plasmin  	plasmin  	 NNS	B-NP
( 	( 	 -LRB-	O
0.1  	0.1  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml 	ml 	 CD	I-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
37°C  	37°C  	 CD	O
for  	for  	 IN	O
30  	30  	 CD	O
min  	min  	 NN	B-NP
with  	with  	 IN	O
same  	same  	 JJ	O
amount  	amount  	 NN	O
of  	of  	 IN	O
wtPAI-1 	wtPAI-1 	 NNP	B-NP
,  	,  	 ,	O
E351A  	E351A  	 NNP	O
and  	and  	 CC	O
E351R  	E351R  	 CD	O
in  	in  	 IN	O
term  	term  	 NN	O
of  	of  	 IN	O
inhibitory  	inhibitory  	 JJ	B-NP
activity  	activity  	 NN	I-NP
toward  	toward  	 IN	O
uPA  	uPA  	 NNP	B-NP
( 	( 	 -LRB-	O
20  	20  	 CD	O
U  	U  	 NNP	O
in  	in  	 IN	O
the  	the  	 DT	O
concentration  	concentration  	 NN	B-NP
range  	range  	 NN	I-NP
of  	of  	 IN	O
4-10  	4-10  	 FW	O
μg 	μg 	 FW	B-NP
/ 	/ 	 FW	I-NP
ml 	ml 	 FW	I-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
absence  	absence  	 NN	B-NP
or  	or  	 CC	O
presence  	presence  	 NN	O
of  	of  	 IN	O
vitronectin  	vitronectin  	 NNS	B-NP
( 	( 	 -LRB-	O
60  	60  	 CD	O
μg 	μg 	 CD	B-NP
/ 	/ 	 CD	I-NP
ml 	ml 	 CD	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Linear  	Linear  	 NNP	B-NP
increase  	increase  	 NN	I-NP
of  	of  	 IN	I-NP
absorbance  	absorbance  	 NN	I-NP
at  	at  	 IN	O
405  	405  	 CD	O
nm  	nm  	 NNS	B-NP
were  	were  	 VBD	O
recorded  	recorded  	 VBN	O
after  	after  	 IN	O
adding  	adding  	 VBG	B-NP
S-2238  	S-2238  	 NNP	I-NP
( 	( 	 -LRB-	O
final  	final  	 JJ	B-NP
concentration  	concentration  	 NN	I-NP
0.25  	0.25  	 CD	O
mM 	mM 	 NN	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
thrombin 	thrombin 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
N-p-Tosyl-Gly-Pro-Lys-p-Nitroanilide  	N-p-Tosyl-Gly-Pro-Lys-p-Nitroanilide  	 NNP	B-NP
( 	( 	 -LRB-	O
final  	final  	 JJ	B-NP
concentration  	concentration  	 NN	I-NP
0.5  	0.5  	 CD	O
mM 	mM 	 NN	O
)  	)  	 -RRB-	O
for  	for  	 IN	O
plasmin 	plasmin 	 NN	B-NP
.  	.  	 .	O
Thrombin 	Thrombin 	 NNP	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
plasmin  	plasmin  	 JJ	B-NP
activity  	activity  	 NN	I-NP
without  	without  	 IN	O
PAI-1  	PAI-1  	 NNP	B-NP
was  	was  	 VBD	O
taken  	taken  	 VBN	O
as  	as  	 IN	O
100 	100 	 CD	O
% 	% 	 NN	O
.  	.  	 .	O
Neutralization  	Neutralization  	 NN	B-NP
of  	of  	 IN	I-NP
PAI-1s  	PAI-1s  	 CD	I-NP
by  	by  	 IN	O
Thrombin  	Thrombin  	 NNP	B-NP
wtPAI-1  	wtPAI-1  	 NNP	I-NP
and  	and  	 CC	O
mutants  	mutants  	 NNS	B-NP
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
four  	four  	 CD	O
molar  	molar  	 JJ	B-NP
excess  	excess  	 NN	I-NP
of  	of  	 IN	I-NP
thrombin  	thrombin  	 NNS	I-NP
( 	( 	 -LRB-	O
40  	40  	 CD	O
nM 	nM 	 NN	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
or  	or  	 CC	O
presence  	presence  	 NN	O
of  	of  	 IN	O
vitronectin  	vitronectin  	 NNS	B-NP
( 	( 	 -LRB-	O
30  	30  	 CD	O
nM 	nM 	 NN	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Control  	Control  	 NN	B-NP
experiments  	experiments  	 NNS	I-NP
were  	were  	 VBD	O
carried  	carried  	 VBN	O
out  	out  	 RP	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	I-NP
thrombin 	thrombin 	 NN	I-NP
.  	.  	 .	O
After  	After  	 IN	O
20  	20  	 CD	O
min  	min  	 NN	B-NP
at  	at  	 IN	O
37°C 	37°C 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
thrombin  	thrombin  	 NN	B-NP
was  	was  	 VBD	O
quenched  	quenched  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
addition  	addition  	 NN	B-NP
of  	of  	 IN	I-NP
hirudin  	hirudin  	 NNS	I-NP
( 	( 	 -LRB-	O
final  	final  	 JJ	B-NP
concentration 	concentration 	 NN	I-NP
,  	,  	 ,	O
60  	60  	 CD	O
units  	units  	 NNS	O
/ 	/ 	 CD	O
ml 	ml 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
resulting  	resulting  	 VBG	O
in  	in  	 IN	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
more  	more  	 JJR	O
than  	than  	 IN	O
95 	95 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
amidolytic  	amidolytic  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
thrombin 	thrombin 	 NN	I-NP
.  	.  	 .	O
Subsequently 	Subsequently 	 RB	O
,  	,  	 ,	O
the  	the  	 DT	O
residual  	residual  	 JJ	B-NP
PAI-1  	PAI-1  	 CD	I-NP
inhibitory  	inhibitory  	 JJ	I-NP
activity  	activity  	 NN	I-NP
was  	was  	 VBD	O
determined  	determined  	 VBN	O
by  	by  	 IN	O
titration  	titration  	 NN	B-NP
of  	of  	 IN	I-NP
aliquots  	aliquots  	 NN	I-NP
on  	on  	 IN	O
uPA 	uPA 	 NNP	B-NP
,  	,  	 ,	O
using  	using  	 VBG	O
S2444  	S2444  	 NN	O
as  	as  	 IN	O
substrate 	substrate 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
increase  	increase  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
optical  	optical  	 JJ	B-NP
density  	density  	 NN	I-NP
at  	at  	 IN	O
405  	405  	 CD	O
nm  	nm  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
samples  	samples  	 NNS	O
was  	was  	 VBD	O
corrected  	corrected  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
values  	values  	 NNS	O
measured  	measured  	 VBN	O
with  	with  	 IN	O
( 	( 	 -LRB-	O
hirudin-inactivated 	hirudin-inactivated 	 NNP	B-NP
)  	)  	 -RRB-	O
thrombin  	thrombin  	 VBZ	O
alone 	alone 	 RB	O
,  	,  	 ,	O
since  	since  	 IN	O
the  	the  	 DT	O
amidolytic  	amidolytic  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
thrombin  	thrombin  	 NN	I-NP
on  	on  	 IN	O
S2444  	S2444  	 NNP	O
was  	was  	 VBD	O
not  	not  	 RB	O
completely  	completely  	 RB	O
blocked  	blocked  	 VBN	O
by  	by  	 IN	O
hirudin 	hirudin 	 NN	B-NP
,  	,  	 ,	O
Complex  	Complex  	 JJ	B-NP
formation  	formation  	 NN	I-NP
of  	of  	 IN	I-NP
PAI-1s  	PAI-1s  	 CD	I-NP
with  	with  	 IN	O
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA  	uPA  	 JJ	B-NP
Complex  	Complex  	 JJ	I-NP
formation  	formation  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
fibrosarcoma  	fibrosarcoma  	 JJ	I-NP
PAI-1 	PAI-1 	 NN	I-NP
,  	,  	 ,	O
wtPAI-1  	wtPAI-1  	 NNP	B-NP
or  	or  	 CC	O
its  	its  	 PRP$	O
mutants  	mutants  	 NN	B-NP
with  	with  	 IN	O
single-chain  	single-chain  	 JJ	B-NP
tPA  	tPA  	 JJ	O
or  	or  	 CC	O
uPA  	uPA  	 NNP	B-NP
were  	were  	 VBD	O
performed  	performed  	 VBN	O
as  	as  	 RB	O
described  	described  	 VBN	O
earlier  	earlier  	 RBR	O
[  	[  	 -LRB-	O
20  	20  	 CD	O
]  	]  	 -RRB-	O
.  	.  	 .	O
Samples  	Samples  	 NNS	O
of  	of  	 IN	O
PAI-1s  	PAI-1s  	 NNP	B-NP
( 	( 	 -LRB-	O
5  	5  	 CD	O
U 	U 	 NNP	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
or  	or  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
2-fold  	2-fold  	 JJ	O
excess  	excess  	 NN	O
of  	of  	 IN	O
uPA  	uPA  	 JJ	O
or  	or  	 CC	O
tPA  	tPA  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
activity  	activity  	 NN	B-NP
assay  	assay  	 NN	I-NP
buffer 	buffer 	 NN	I-NP
.  	.  	 .	O
Following  	Following  	 VBG	O
a  	a  	 DT	O
30  	30  	 CD	O
min  	min  	 JJ	B-NP
incubation  	incubation  	 NN	I-NP
at  	at  	 IN	O
room  	room  	 NN	B-NP
temperature 	temperature 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
subjected  	subjected  	 VBN	O
to  	to  	 TO	O
a  	a  	 DT	O
10 	10 	 CD	O
%  	%  	 NN	O
SDS-PAGE  	SDS-PAGE  	 NN	B-NP
and  	and  	 CC	O
immunoblotting  	immunoblotting  	 VBP	O
as  	as  	 RB	O
described  	described  	 VBN	O
above 	above 	 IN	O
.  	.  	 .	O
Abbreviations  	Abbreviations  	 NNP	B-NP
tPA 	tPA 	 NNP	I-NP
,  	,  	 ,	O
tissue-type  	tissue-type  	 JJ	B-NP
plasminogen  	plasminogen  	 JJ	I-NP
activator 	activator 	 NN	I-NP
;  	;  	 :	O
uPA 	uPA 	 NNP	B-NP
,  	,  	 ,	O
urokinase-type  	urokinase-type  	 JJ	B-NP
plasminogen  	plasminogen  	 JJ	I-NP
activator 	activator 	 NN	I-NP
;  	;  	 :	O
PAI-1 	PAI-1 	 CD	B-NP
,  	,  	 ,	O
plasminogen  	plasminogen  	 FW	B-NP
activator  	activator  	 FW	I-NP
inhibitor  	inhibitor  	 FW	I-NP
type  	type  	 NN	I-NP
1 	1 	 CD	O
;  	;  	 :	O
serpin 	serpin 	 CD	B-NP
,  	,  	 ,	O
serine  	serine  	 FW	B-NP
protease  	protease  	 FW	I-NP
inhibitor 	inhibitor 	 FW	I-NP
;  	;  	 :	O
RCL 	RCL 	 NNP	B-NP
,  	,  	 ,	O
reactive  	reactive  	 JJ	B-NP
center  	center  	 NN	I-NP
loop 	loop 	 NNS	I-NP
;  	;  	 :	O
Vn 	Vn 	 NNP	B-NP
,  	,  	 ,	O
vitronectin 	vitronectin 	 NN	B-NP
,  	,  	 ,	O
SDS 	SDS 	 NNP	B-NP
,  	,  	 ,	O
sodium  	sodium  	 JJ	B-NP
dodecylsulfate 	dodecylsulfate 	 NN	I-NP
;  	;  	 :	O
PAGE 	PAGE 	 NNP	O
,  	,  	 ,	O
polyacrylamide  	polyacrylamide  	 FW	B-NP
gel  	gel  	 FW	I-NP
electrophoresis 	electrophoresis 	 FW	I-NP
.  	.  	 .	O
Gdn-HCl 	Gdn-HCl 	 NNP	B-NP
,  	,  	 ,	O
guanidine-hydrochloride 	guanidine-hydrochloride 	 JJ	B-NP
;  	;  	 :	O
HRP 	HRP 	 NNP	B-NP
,  	,  	 ,	O
horseradish  	horseradish  	 JJ	B-NP
peroxidase 	peroxidase 	 NN	I-NP
;  	;  	 :	O
ECL 	ECL 	 NNP	B-NP
,  	,  	 ,	O
enhanced  	enhanced  	 JJ	O
chemiluminescence 	chemiluminescence 	 NN	B-NP
;  	;  	 :	O
PBS 	PBS 	 NNP	B-NP
,  	,  	 ,	O
phosphate-buffered  	phosphate-buffered  	 JJ	B-NP
saline 	saline 	 NN	I-NP
;  	;  	 :	O
BSA 	BSA 	 NNP	B-NP
,  	,  	 ,	O
bovine  	bovine  	 FW	B-NP
serum  	serum  	 FW	I-NP
albumin 	albumin 	 FW	I-NP
.  	.  	 .	O
Authors 	Authors 	 NNP	O
'  	'  	 POS	O
contribution  	contribution  	 NN	O
Qingcai  	Qingcai  	 NNP	O
Wang  	Wang  	 NNP	O
carried  	carried  	 VBD	O
out  	out  	 RP	O
the  	the  	 DT	O
experiments  	experiments  	 NNS	O
and  	and  	 CC	O
drafted  	drafted  	 VBD	O
the  	the  	 DT	O
manuscript 	manuscript 	 NN	O
;  	;  	 :	O
Professor  	Professor  	 NNP	B-NP
Shmuel  	Shmuel  	 NNP	I-NP
Shaltiel  	Shaltiel  	 NNP	I-NP
sponsored  	sponsored  	 NN	I-NP
and  	and  	 CC	O
supervised  	supervised  	 VBD	O
the  	the  	 DT	O
project  	project  	 NN	B-NP
and  	and  	 CC	O
revised  	revised  	 VBN	O
the  	the  	 DT	O
manuscript 	manuscript 	 NN	O
.  	.  	 .	O
